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Abstract

Purpose: The purpose of this translational research project was to outline the healthcare
problems associated with Functional Gastrointestinal Disorders and to explore the effectiveness
of a gastrointestinal protocol utilized at Atlanta Center for Holistic and Integrative Medicine. The
goal of this protocol is to restore digestive health with probiotics, digestive enzymes, and
glutamine.
Background: Functional Gastrointestinal Disorders affect one in every four adults in the United
States. These disorders encompass a variety of symptoms including diarrhea, constipation,
cramping, abdominal pain, flatulence, reflux, and bloating without an identified physiological
cause. There is currently no cure for Functional Gastrointestinal Disorders and treatment focuses
on symptom management. The majority of those suffering from Functional Gastrointestinal
Disorders are unsatisfied with their current treatment regimen leading to physical, social, and
emotional distress.
Method: This prospective cohort study examined 98 adult participants with Functional
Gastrointestinal Disorders. Each participant was instructed to take probiotics, digestive enzymes,
and glutamine daily for 8-weeks. The participants were evaluated by a virtual survey at baseline,
weekly, and after 8-weeks of intervention. The pre and post-intervention surveys included age,
gender, ethnicity, duration of symptoms, number of attempted treatments, weight, waist
circumference, the Perceived Stress Scale, and the Gastrointestinal Quality of Life Index.
Results: A total of 86 participants completed the entire 8-week intervention. Based on the results
of this study, there were three statistically significant predictors of lower gastrointestinal quality
of life based on the Gastrointestinal Quality of Life. These three predictors include (1)
minorities, (2) higher levels of stress based on the Perceived Stress Scale, and (3) greater than 3

RESTORING DIGESTIVE HEALTH
attempted treatments. After the 8-week intervention, the participants had significant weight loss
and improved gastrointestinal quality of life scores.
Discussion: This research study is the first to examine the combined benefits of probiotics,
digestive enzymes, and glutamine. In this study, participants had significant improvements in
weight loss and gastrointestinal quality of life indicating that this protocol can be an effective
regimen for treating patients with Functional Gastrointestinal Disorders.

KEY WORDS: Functional Gastrointestinal Disorders, Perceived Stress, Gastrointestinal
Quality of Life, Weight, Waist Circumference
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Restoring Digestive Health with Probiotics, Digestive Enzymes, and Glutamine
CHAPTER I
Introduction
Gastrointestinal disorders are highly prevalent in the United States. The majority of
gastrointestinal symptoms reported to healthcare providers are functional disorders rather than
disease states (Stake-Nilsson, Hultcrantz, Unge, & Wengström, 2012). Disease states are
associated with a specific underlying pathology that can be identified through diagnostic testing,
while functional disorders have an unknown structural or physiological abnormality (StakeNilsson et al., 2012). The term used to identify this syndrome is Functional Gastrointestinal
Disorders. This population often experiences little to no improvement in their symptoms, leading
to physical, mental, and social distress (Markert, Suarez-Hitz, Ehlert, & Nater, 2014; Spiegel et
al., 2011; Stake-Nilsson et al., 2012).
Understanding Functional Gastrointestinal Disorders
Definition
The term Functional Gastrointestinal Disorders is used when the body’s digestive tract
seems to be functioning normally, yet it causes significant gastrointestinal symptoms in an
individual’s quality of life. Examples of this in the gastrointestinal system are changes in the
motility of the intestines, sensitivity of the nerves in the intestines, or the way in which the brain
controls the functions of the digestive tract (International Foundation of Functional
Gastrointestinal Disorders [IFFGD], 2015). Despite the impaired function, healthcare providers
are unable to identify a structural abnormality through diagnostic testing, such as endoscopy,
colonoscopy, CT scan, x-ray, or blood tests (IFFGD, 2015). In other words, Functional
Gastrointestinal Disorders are defined as chronic or recurrent gastrointestinal symptoms, such as
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pain, heartburn, abdominal distention, nausea, vomiting, bloating, constipation, or diarrhea,
without a known structural or biochemical abnormality (Markert et al., 2014).
Prevalence
Functional Gastrointestinal Disorders are the most common gastrointestinal disorder seen
in the general public, affecting one in every four people in the United States (IFFGD, 2015).
Some of the most common Functional Gastrointestinal Disorders include functional dyspepsia,
irritable bowel syndrome, and functional constipation. Functional dyspepsia affects 20-30% of
the general population followed by functional constipation (up to 27%) and irritable bowel
syndrome (10-20%) (IFFGD, 2009). These disorders make up 41% of all gastrointestinal
symptoms reported to healthcare providers and therapists (IFFGD, 2015). Functional
Gastrointestinal Disorders seem to affect females more frequently than males, yet the etiology
behind this remains unknown (Markert et al., 2014).
Functional Dyspepsia is defined as symptoms that originate from the upper digestive
system including the stomach and small intestines without any structural or metabolic diseases
known (IFFGD, 2015). This disorder is estimated to affect 30% of the general population
(IFFGD, 2015). Symptoms of dyspepsia vary tremendously including burning, pressure, fullness,
nausea, early satiety, belching, and bloating. This disorder is often chronic with approximately
50% of patients having symptoms of functional dyspepsia for over 5-years (IFFGD, 2015).
Two of the most common digestive disorders include irritable bowel syndrome and
inflammatory bowel disease. These two disorders affect 16.3 million people in the United States
alone (McCormick et al., 2012). Irritable bowel syndrome patients account for 3.65 million
outpatient provider visits annually (IFFGD, 2009). Unlike irritable bowel syndrome,
inflammatory bowel disease is a true disease state that encompasses both Ulcerative Colitis and
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Crohn’s Disease. With this diagnosis, there is clear evidence to support the etiology of
inflammation within the digestive tract. In contrast, irritable bowel syndrome is classified as a
Functional Gastrointestinal Disorder because there is no structural abnormality associated with
the disorder and the etiology remains vague and inconclusive. Functional constipation is defined
as difficult, infrequent, and often incomplete defecation without a known cause (IFFGD, 2015).
Etiology
Despite increasing research, the pathophysiology behind Functional Gastrointestinal
Disorders remains ambiguous and treatment options are limited (Markert et al., 2014). Current
evidence suggests that the etiology behind Functional Gastrointestinal Disorders is
biopsychosocial in nature (Markert et al., 2014). Over the past two decades, specific
organizations, such as the International Foundation of Functional Gastrointestinal Disorders
(IFFGD) have discovered some possible mechanisms behind the development of Functional
Gastrointestinal Disorders (IFFGD, 2009). These discoveries have found abnormalities in the
brain-gut communication, genetic factors, infection, altered gut bacteria, and intestinal
inflammation (IFFGD, 2009). Two thirds of these patients are thought to have an increased
sensitivity to gut stimuli or “visceral hypersensitivity”; others suffer from abnormal motility that
can cause a wide range of symptoms including swallowing difficulties, heartburn, diarrhea,
constipation, and incontinence (IFFGD, 2009). Other researchers are questioning the association
between medication use and Functional Gastrointestinal Disorders. A population-based study
was conducted to determine whether proton pump inhibitors (PPI), antidepressants, and/or
narcotics were contributing to the high prevalence of Functional Gastrointestinal Disorders
(Choung, Locke, Schleck, Zinsmeister, & Talley, 2013). The results found that PPI use was
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causing significant irritable bowel syndrome and dyspepsia symptoms, while antidepressant use
was significantly associated with bloating (Choung et al., 2013).
Brain-Gut Communication. Research concerning the brain-gut connection is
continually evolving. External and internal stressors may have an effect on gastrointestinal
motility and sensation. For example, some individuals may experience the sensation of
butterflies in their stomach when anxious or an upset stomach related to other emotions, such as
sadness (IFFGD, 2009). Pain is often a subjective symptom associated with Functional
Gastrointestinal Disorders. When assessing pain, it is important to evaluate how the brain is
responding to the signal. Patients diagnosed with irritable bowel syndrome were shown to have
more brain activation in the area responsible for afferent processing and emotional arousal
compared to the control group (Tillisch & Labus, 2011). Structurally, the amount of gray matter
an individual has may be a factor in chronic illnesses. For example, individuals suffering from a
variety of illnesses including chronic pain, depression, and irritable bowel syndrome have been
shown to have varying amounts of gray matter (Tillisch & Labus, 2011). Specifically, irritable
bowel syndrome was associated with decreased gray matter density in several areas of the brain
(Tillisch & Labus, 2011).
Genetic Factors. Functional Gastrointestinal Disorders have been shown to run in
families (IFFGD, 2009). Research is beginning to identify genes that may predispose individuals
to Functional Gastrointestinal Disorders. For example, the beta-2 adrenergic receptor (ADRB2)
is an essential target for epinephrine, which is a pain signaling neurotransmitter. Evidence has
found ADRB2 minor alleles at rs1042714 to be a predictor for Functional Gastrointestinal
Disorders and may influence bowel symptom severity and quality of life (Kushnir et al., 2013).
Another polymorphism examined is the Serotonin Transporter (SERT) role in irritable bowel
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syndrome. In patients with irritable bowel syndrome, this gene has been shown to play a key role
in motility-related symptoms (Wang et al., 2012).
Infection and Intestinal Inflammation. Individuals that suffer from a gastrointestinal
infection have a higher risk of developing irritable bowel syndrome symptoms that can persist
for months to years (IFFGD, 2009). It is hypothesized that these symptoms may be the result of
persistent, low-grade inflammation (IFFGD, 2009). Current research supports that individuals
suffering from functional dyspepsia and irritable bowel syndrome have a higher risk of
developing bouts of infectious gastroenteritis (Simrén et al., 2013). Porter et al. (2011) conducted
a study on 31,866 U.S Military personnel diagnosed with Functional Gastrointestinal Disorders
to examine the association between Functional Gastrointestinal Disorders and infectious
gastroenteritis. The results of this study showed a significant association between Functional
Gastrointestinal Disorders and infectious gastroenteritis (p< 0.001) (Porter et al., 2011). The
distribution is as follows: specific bacterial pathogen (1.2%), bacterial without a specific
pathogen identified (38.9%), protozoal (0.7%), and viral (61.9%) (Porter et al., 2011).
In the United Kingdom, a large study was conducted to assess the association of
autoimmune disease and Functional Gastrointestinal Disorders (Ford, Talley, Walker, & Jones,
2014). This study examined the prevalence of autoimmune disorders among 23,471 patients with
Functional Gastrointestinal Disorders including functional diarrhea, chronic idiopathic
constipation, or multiple Functional Gastrointestinal Disorders. The results of this study found
that those suffering from rheumatologic autoimmune disorders had a significantly higher
incidence of Functional Gastrointestinal Disorders including functional diarrhea, chronic
idiopathic constipation, and multiple Functional Gastrointestinal Disorders (Ford, Talley, et al.,
2014).
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Altered Gut Bacteria. One of the most recent hypotheses for Functional Gastrointestinal
Disorders is that an abnormal intestinal microflora can activate mucosal innate immune system
responses that increase the epithelial permeability, activate nociceptive sensory pathways, and
dysregulate the enteric nervous system (Simrén et al., 2013). In the human digestive tract, there
are more than 500 different species with an immense variety of aerobic and anaerobic bacteria
(Ringel & Ringel-Kulka, 2011). Some of these bacteria are known to be beneficial to a person’s
health by helping to maintain a normal functioning intestine; while other bacteria can cause
infection, or inflammation. When the normal balance in the intestine between beneficial and
harmful bacteria is changed, it may lead to changes in the function of the gastrointestinal tract
and cause chronic gastrointestinal symptoms (IFFGD, 2009).
Costs
In the United States, gastrointestinal disorders are the leading cause of outpatient office
visits (Myer et al., 2013). Unfortunately the only data available was from 2004, which indicated
72 million outpatient office visits in the United States were associated with a gastrointestinal
diagnosis (Myer et al., 2013). Women had a 20% higher rate of ambulatory visits than men, with
no differences observed between Caucasians and African Americans (Myer et al., 2013). It is
estimated that Functional Gastrointestinal Disorders are costing our society over $30 billion
annually (IFFGD, 2009). Direct costs associated with irritable bowel syndrome alone are
estimated at $1.5 billion annually and as high as $10 billion in adjusted costs, excluding
prescriptions and over the counter medications (IFFGD, 2009). It is estimated that indirect costs
associated with irritable bowel syndrome may be as high as $20 billion annually from decreased
work productivity (IFFGD, 2009).

RESTORING DIGESTIVE HEALTH

17

Healthcare costs related to gastrointestinal disorders expand beyond outpatient care. In
2007, there were 15.1 million emergency room visits associated with gastrointestinal symptoms
(Myer et al., 2013). The total annual charges for all Emergency Department visits with a primary
gastrointestinal diagnosis was $27.9 billion with each visit averaging $2,354 (Myer et al., 2013).
Symptoms and Treatment
The symptoms associated with Functional Gastrointestinal Disorders vary greatly and in
some cases the symptoms overlap. Common symptoms include abdominal pain, bloating,
heartburn, nausea, constipation, diarrhea, bloating, urgency, decreased appetite, swallowing
difficulties, and incontinence (IFFGD, 2009). Unfortunately, there is no cure for Functional
Gastrointestinal Disorders; rather treatment focuses on symptom management and improvements
in patients’ overall quality of life. Current treatment modalities include antidepressants to
decrease intestinal hypersensitivity, relaxation techniques, avoiding known food triggers,
medications to regulate bowel function, biofeedback therapy, hypnosis, and cognitive behavior
therapy to help restore a sense of control over the disorder (IFFGD, 2009). Even these treatments
have limited efficacy and have potential adverse effects (Hungin et al., 2013). Further research is
needed for a safe and effective long-term treatment for Functional Gastrointestinal Disorders
symptoms (Waller et al., 2011).
Purpose and Clinical Question
Maintaining a normally functioning gastrointestinal tract is essential for health. The
gastrointestinal tract is a large organ in the human body encompassing everything from the
mouth to the anus. The intestinal mucosa is the body’s primary line of defense against toxins and
bacteria (Resnick, 2010). Mucosal damage and intestinal inflammation can progress to chronic
disease, autoimmune responses, and systemic inflammation (Resnick, 2010). Several conditions
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are associated with intestinal permeability defects including multiple organ failure, chronic
fatigue syndrome, ulcerative colitis, Crohn’s disease, celiac disease, irritable bowel syndrome,
juvenile onset arthritis, food allergies, chronic heart failure, and psychological conditions, such
as depression and anxiety (Resnick, 2010). Long-term gastrointestinal reflux disease increases
the risk of esophageal strictures, esophageal ulcers, or precancerous cells, as seen in Barrett’s
esophagus (Mayo Clinic, n.d.). Chronic diarrhea is associated with malabsorption; this can cause
complications including electrolyte imbalances, dehydration, vitamin deficiencies, diminished
urine output, kidney failure, and orthostatic hypotension (Marks, 2014).
The specific aim of this project was to outline the healthcare problems associated with
functional gastrointestinal disorders and to explore the effectiveness of a gastrointestinal protocol
implemented at Atlanta Center for Holistic and Integrative Medicine (ACHIM). This protocol
was designed to help restore digestive health. Conventional medications play a key role in
improving gastrointestinal disorders outcomes; such as proton pump inhibitors and antibiotics for
the treatment of H pylori. However, all medications come with potential adverse effects. For
example, long term use of proton pump inhibitors is associated with pneumonia, fractures,
vitamin B12 deficiencies, hypomagnesaemia, and pneumonia (Owen, Marks, & Banks, 2014).
The goal of ACHIM’s gastrointestinal protocol was to naturally heal and restore a normal
functioning digestive system with minimal to no adverse effects. The purpose of this project was
to determine if adult patients with functional gastrointestinal disorders report improved
abdominal symptoms based on the Gastrointestinal Quality of Life Index after eight weeks of
probiotics, digestive enzymes, and glutamine. This translational project was designed to
quantify the benefits associated with this well-established protocol. A thorough literature review
and synthesis of evidence related to probiotics, digestive enzymes, and glutamine was conducted
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and the pertinent results are disseminated throughout this paper. The paper concludes with a
thorough discussion of the research findings. Below is a list of the clinical research questions.
Pre-Intervention Clinical Questions
1. What demographic factors (age, gender, ethnicity, duration of symptoms, and number of
attempted treatments) are associated with a lower level of gastrointestinal quality of life?
2. What is the association between patients’ perceived stress and gastrointestinal quality of
life?
3. Controlling for demographic variables (age, gender, ethnicity, duration of symptoms, and
number of attempted treatments) what is the association of perceived stress on
gastrointestinal quality of life?
4. What demographic factors (age, gender, ethnicity, duration of symptoms and number of
attempted treatments) are associated with an increased weight and weight circumference?
5. Controlling for demographic variables (age, gender, ethnicity, duration of symptoms, and
number of attempted treatments), what is the association between perceived stress and
waist circumference and weight?
6. Controlling for demographic variables (age, gender, ethnicity, duration of symptoms, and
number of attempted treatments), is there an association between gastrointestinal quality
of life and weight and waist circumference?
Post-Intervention Clinical Questions
7. After 8-week treatment with probiotics, digestive enzymes, and glutamine, is there an
association between patients' perceived stress and gastrointestinal quality of life?
8. Controlling for demographic variables (age, gender, ethnicity, duration of symptoms, and
number of attempted treatments) after 8-week treatment with probiotics, digestive
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enzymes, and glutamine, what is the association of perceived stress on gastrointestinal
quality of life?
9. Controlling for demographic variables (age, gender, ethnicity, duration of symptoms, and
number of attempted treatments) after 8-week treatment with probiotics, digestive
enzymes, and glutamine, what is the association between perceived stress and waist
circumference and weight?
10. Controlling for demographic variables (age, gender, ethnicity, duration of symptoms, and
number of attempted treatments) after 8-week treatment with probiotics, digestive
enzymes, and glutamine, what is the association between gastrointestinal quality of life
and weight and waist circumference?
11. After 8-week treatment with probiotics, digestive enzymes, and glutamine, is there a
statistically significant change in the gastrointestinal quality of life, weight, waist
circumference, and perceived stress?
Challenges
Integrative Medicine utilizes both conventional and alternative medicine modalities to
improve the patient’s overall healthcare outcomes. Since integrative medicine incorporates nonmainstream therapies, the scientific evidence is limited, making elements of the literature review
challenging. Restoring digestive health is a multi-factorial concept. Several factors play a role in
restoring digestive health including stress reduction, brain-gut connection, and ruling out any
food intolerances and allergies. This study did not alter participants’ diet or lifestyle. It primarily
examined the benefits of probiotics, digestive enzymes, and glutamine on restoring digestive
health.
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CHAPTER II

Review of Literature
Recently, research has gained interest in the importance of gut-related health problems,
such as the increasing evidence that a poor digestive tract is associated with autoimmune
diseases and inflammatory processes (Ritchie & Romanuk, 2012). The restoring digestive health
protocol utilized at the Atlanta Center for Holistic and Integrative Medicine is unique to the
practice. Consequently, there is not any research to support the combination of probiotics,
digestive enzymes, and glutamine on digestive health. Therefore, a comprehensive literature
review was conducted to assess the effectiveness of probiotics, digestive enzymes, and glutamine
individually. A separate literature review was conducted to find a valid and reliable instrument
that measures gastrointestinal symptoms. Each literature review was conducted primarily
through GALILEO and Google Scholar. All articles included in this literature review were peerreviewed, scholarly articles.
Probiotics
The large amount of bacteria in the digestive tract is known as the intestinal microflora.
In the human digestive tract, it is estimated that the intestinal microflora contains 1014 cells,
which is thought to be ten times more than the number of cells in the entire human body (Simrén
et al., 2013). The intestinal microflora has been researched heavily in recent years for its
potential influence on gastrointestinal symptoms and diseases. Some of these organisms have
been shown to be beneficial to one’s health, while others may cause infection or inflammation
(IFFGD, 2009). When the normal balance in the intestines between beneficial and harmful
bacteria changes, it may lead to negative results in the function of the gastrointestinal tract
(IFFGD, 2009).

RESTORING DIGESTIVE HEALTH

22

The beneficial bacteria for the digestive tract are known as probiotics. The term probiotic
is derived from the Latin words “pro” and “bios” meaning “for life” (Castellazzi et al., 2013). Eli
Metchnikoff first coined the term probiotic in 1907 (Castellazzi et al., 2013). He was the first
man to propose the notion that consuming live microorganisms may have potentially beneficial
effects on human’s overall health (Castellazzi et al., 2013). Probiotics can be supplemented or
naturally found in foods, such as yogurt, kefir, miso, tempeh, and teas like Kombucha. Basically,
probiotics are live microorganisms that help maintain and restore beneficial intestinal microflora
that have the ability to prevent or treat gastrointestinal disorders and other related systemic
conditions (Resnick, 2010). Restoring the normal flora in the digestive tract is crucial for
digestive health, because probiotics can act as an intestinal barrier to pathogen causing
microorganisms (Rao & Samak, 2013).
In the United States, there has been an overall improvement in hygiene and nutrition that
has resulted in a significant reduction in overall bacteria exposure, including beneficial bacteria
(Ritchie & Romanuk, 2012). Through experimentation, it is known that gut microflora is
essential to the normal development of the immune system, growth and development (Hickson,
2013). Probiotics have been shown to be beneficial for cytoprotection, cell proliferation, cell
migration, resistance to apoptosis, and synthesis of proteins and gene expression (Rao & Samak,
2013). The beneficial properties of probiotics include protective barriers, enhancing immune
responses, and clearing pathogens in the gastrointestinal tract (Ritchie & Romanuk, 2012).
One study found that supplementing probiotics significantly helped treat inflammatory
bowel disease (Cary & Boullata, 2010). Other symptom improvements seen with probiotics
include a reduction in abdominal pain and bloating (Jafari, Vahedi, Merat, Momtahen, & Riahi,
2014; Rogha, Esfahani, & Zargarzadeh, 2014). Probiotics have the ability to significantly
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improve whole gut transit time by up to 12.4 hours, improve stool consistency, and increase stool
frequency by 1.3 bowel movements per week in patients with constipation (Dimidi,
Christodoulides, Fragkos, Scott, & Whelan, 2014).
Probiotics can be bacteria or yeast. The most common bacterial probiotics include
Lactobacillus and Bifidobacterium groups. These include a number of different strains including
L. rhamonusus, L. bulgaricus, L. salivarius, L. plantarum, L. casei, B. infantis, and B. longum.
The most common beneficial yeast is Saccharomyces boulardii. In order for probiotics to be
effective, they must be able to adhere to the gut epithelium cells, eliminate or reduce pathogenic
adherence, produce and multiply acids, such as, hydrogen peroxide, which will ultimately protect
the digestive tract against pathogen growth (Castellazzi et al., 2013).
Research on the benefit of probiotic supplementation is often strain specific (Waller et
al., 2011). For example, L. rhamnosus GG is a specific strain that has been shown to be
beneficial in antibiotic-associated diarrhea (Hickson, 2013; McFarland, 2008; Suardi, Crippa, &
Monforte, 2013). This is important because in the United States, it is estimated that 258 million
course of antibiotics were prescribed in 2010; that is 833 antibiotic prescriptions per 1,000
people (Hickson, 2013). The incidence of antibiotic associated diarrhea is estimated to affect up
to 30% of adults prescribed antibiotics (McFarland, 2008). Probiotics can be recommended
prophylactically to prevent antibiotic associated diarrhea. Individuals that supplement probiotics
containing S. boulardii while taking an antibiotic have half the risk of getting antibiotic
associated diarrhea compared to those not taking this yeast (Hickson, 2013).
Bifidobacterium lactic HN019 is a probiotic strain for which many health benefits have
been established, primarily related to immune enhancement (Waller et al., 2011). Dietary
consumption of the probiotic B. lactis HN019 is well tolerated, decreases whole gut transit time
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in a dose-dependent manner, and reduces the frequency of functional gastrointestinal symptoms
in adults (Waller et al., 2011).
According to the Natural Medicines database, the level of evidence associated with
probiotics is a grade A (strong scientific evidence) for acute diarrhea and atopic dermatitis and a
grade B (good scientific evidence) for cirrhosis, dental caries, growth, immune enhancement,
irritable bowel syndrome, sinusitis, and ulcerative colitis (Natural Standards, 2015c). Natural
Medicines is an international research database that maintains up to date, comprehensive
systematic reviews on complementary and alternative medicine. It adheres to the most recent
recommendations of the Institute of Medicine for all systematic reviews and clinical practice
guidelines. The editorial board performs multiple rounds of blinded multidisciplinary peer
review methodologies to ensure the accuracy of the information.
Probiotics have been shown to be safe with minimal adverse effects. Consumers can
easily find probiotics in natural food sources, such as kefir, yogurt, or Kombucha. Probiotics can
also be found in the form of a supplement over the counter at grocery stores or health food
stores. A meta-analysis of 28 randomized controlled studies found probiotics to be safe with no
adverse effects reported in any of the 28 studies (Hungin et al., 2013). Probiotics are not
metabolized through the CYP 450 system; therefore they do not interact with other medications
that are metabolized through the CYP 450 system. The therapeutic dose of probiotics is
important, however the ideal recommended dose remains unclear (Hickson, 2013). There are
currently no clinical guidelines for the recommendation of probiotics in the outpatient setting.
Although there is an abundant amount of evidence to support probiotics, the specific strains,
dose, and duration vary depending on the study conducted. Therefore, future research is needed
to assess what strains, specific doses, and duration are the most beneficial. At Atlanta Center for
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Holistic and Integrative Medicine the protocol for restoring digestive utilizes multi-strain
probiotics with at least 20 billion CFUs.
Glutamine
Glutamine is a functional amino acid that has several beneficial properties in the
digestive tract (Wang et al., 2014). In healthy individuals, glutamine is the most abundant amino
acid in muscles and plasma; however, after injuries, surgeries, or infection, glutamine
concentration significantly decreases (Mochiki et al., 2011). Glutamine is naturally found in
several foods including grass-fed beef, bison, chicken, eggs, whey protein, and certain cheeses.
Health food stores sell glutamine over the counter as a supplement in the form of a capsule or
powder. Glutamine is often added to protein powders or other nutritional shakes. L-glutamine
has been shown to help maintain the intestinal barrier function and help fight off foreign
microorganisms including bacteria, viruses, and funguses (Resnick, 2010). In recent years,
glutamine has been researched for its role in gut mucosal turnover and function (Mochiki et al.,
2011). Supplementing glutamine for gastrointestinal discomfort has been shown to improve the
intestinal mucosal barrier by regulating the expression of genes and proteins that are involved in
cell proliferation, differentiation, and apoptosis, protein turnover, anti-oxidative property, and
immunity responses (Wang et al., 2014).
Glutamine is required for the normal production of immunoglobulin A in the intestines,
which is a key factor in immune support (Resnick, 2010). Glutamine has been shown to have
anti-inflammatory benefits in the intestinal tract (Ren et al., 2013) and can regulate the
metabolism of intestinal bacteria in the digestive tract (Wang et al., 2014). LDH or Lactate
Dehydrogenase is an enzyme that is released when tissues are damaged. LDH activity was
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significantly decreased (p < 0.05) when participants were given antioxidants and glutamine
(Ziegler, Seddiki, Marion-Letellier, Lavoinne, & Déchelotte, 2011).
Intestinal permeability and morphology was significantly improved with glutamine
supplementation (Benjamin et al., 2012). Glutamine significantly improved motor activity in the
duodenum after gastric surgery (Mochiki et al., 2011). When used at the right dose, glutamine
can be protective and prevent the increasing intestinal permeability seen in patients that are
chronically ill (De-Souza & Greene, 2005; Sevastiadou et al., 2011). The therapeutic dose varies
greatly across each research study; however, the ACHIM’s protocol for restoring digestive health
utilizes 2-3 grams. In practice, this has seemed to be the most beneficial at improving
gastrointestinal symptoms while scientific evidence varies. By decreasing the intestinal
permeability, glutamine can reduce the frequency of infections and reduce the translocation of
intestinal bacteria and toxins (Camilleri, Madsen, Spiller, Van Meerveld, & Verne, 2012; DeSouza & Greene, 2005).
When intestinal permeability is improved, intestinal absorption is improved (Leite et al.,
2013). This is an important concept to understand when treating individuals with diarrhea.
Diarrhea can cause decreased absorption of vitamins and minerals because the total transit time
is increased. One study found that in patients with diarrhea, absorption was significantly
improved with glutamine supplementation (Leite et al., 2013). Glutamine has the power to
improve patients overall gastrointestinal function and health (Camilleri et al., 2012). Therefore, it
is a key component of the restoring digestive health protocol.
The FDA is heavily researching glutamine, with 174 studies being conducted regarding
the effectiveness and safety of glutamine (Clinical Trials, n.d). Glutamine is shown to be safe
with minimal to no risk factors even in studies conducted on premature infants (Sevastiadou et
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al., 2011). Glutamine is not metabolized through the CYP 450 system; therefore it does not
interact with medications that are metabolized in the CYP 450 system. According to Natural
Medicines’ database, glutamine’s level of evidence is a grade A (strong scientific evidence) for
burns and a grade B (good scientific evidence) for total parenteral nutrition during trauma or
post-surgery and grade C (unclear or conflicting scientific evidence) for the critically ill,
inflammatory bowel conditions, mood, malnutrition, septicemia, transplants, and
supplementation in preterm and very low birth weight infants (Natural Standards, 2015a).
Digestive Enzymes
The concept of supplementing digestive enzymes is not new. For over seventy years
scientist have been researching the benefits of digestive enzymes (Stout, 2013). As individuals
age, the amount of digestive enzymes produced by the body declines. Supplementing digestive
enzymes can improve digestion, reduce abdominal distress, and result in a greater assimilation of
vital nutrients like vitamins K, D, and omega-3 and omega-6 (Stout, 2013). Protease helps the
body breakdown protein and absorbs the essential nutrients in proteins (amino acids)
(Stout, 2013; Whitcomb & Lowe, 2007). Lipase helps the body breakdown fatty acids, which is
essential for the absorption of fat-soluble vitamins, such as, vitamin A, E, D, and K (Stout, 2013;
Whitcomb & Lowe, 2007). Digestive enzymes allow the digestive tract to rest and recover.
Adequate digestion is required for gastrointestinal health; inadequate digestive enzymes
are correlated with malabsorption, food intolerance, food allergy, autoimmune, bacterial
overgrowth, and gastrointestinal discomfort (Resnick, 2010). In the small intestine, there are
digestive enzymes that are produced by the pancreas for the hydrolysis of complex nutrients
(Kaur & Sekhon, 2012; Whitcomb & Lowe, 2007). The main digestive enzymes that the body
uses include protease, amylase, sucrase, lipase, lactase, and maltase (Kaur & Sekhon, 2012).
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Digestive enzymes can be supplemented or found naturally in foods. Food enzymes are
produced externally and are derived solely from raw foods like animal or plant products and
supplements. Protease, lipase, amylase, bromelain, and cellulose are plant based while pepsin, is
an animal based enzyme (Kaur & Sekhon, 2012). Naturally occurring food enzymes are found in
bananas, papaya, kiwi, bee pollen, raw honey, avocado, grapes, pineapple, extra virgin olive oil,
dates, and certain raw oils and sprouts (Kaur & Sekhon, 2012). Digestive enzymes particularly
protease, bromelain, and lipase can be extremely beneficial in reducing symptoms and restoring
a balanced digestive tract (Kaur & Sekhon, 2012).
Pancreatic enzyme products contain the active ingredient pancrelipase, a mixture of the
digestive enzymes amylase, lipase, and protease (Kaur & Sekhon, 2012). Cellulase and protease
have been shown to be beneficial in controlling candida overgrowth (Kaur & Sekhon, 2012).
Cellulase enzyme breaks down fiber and it is the only digestive enzyme the body does not make
(Kaur & Sekhon, 2012). The enzyme protease has the ability to hydrolyze protein. Protease has
been used in clinics all over the world to break down Candida and prevent its overgrowth (Kaur
& Sekhon, 2012). Lactase supplements are used to help treat lactose intolerance. Lactase
chewable tablets consists of an enzyme that helps consume dairy foods without producing gas,
cramps, bloating, or diarrhea in the patient (Kaur & Sekhon, 2012). Digestive enzymes are
supplemented in combination with lipase to digest fat, amylase to digest starchy carbohydrates,
and protease to digest protein.
Digestive enzymes as supplements along with meals share the workload of body’s own
pancreatic enzymes for digestion (Kaur & Sekhon, 2012). Pancreatic enzyme replacement
therapy is currently the mainstay of treatment for nutrient malabsorption, secondary pancreatic
insufficiency, cystic fibrosis, chronic pancreatitis, pancreatic and periampullary cancer (Kaur &
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Sekhon, 2012). Reported data demonstrated efficacy in reducing steatorrhea and fat
malabsorption (Kaur & Sekhon, 2012).
Digestive enzymes as supplements may bring improvement in health problems such as
heartburn, indigestion, gastrointestinal reflux disease, diarrhea, constipation, diabetes, bloating,
and host of other health problems (Kaur & Sekhon, 2012). Supplemental proteolytic enzymes are
derived from plant and animal sources. Common proteases include bromelain from pineapple,
papain and chymopapain from papaya (Kaur & Sekhon, 2012). The fungal protease from the
Aspergillus oryzae fungi and the trypsin, chymotrypsin, and pancreatin usually from porcine or
bovine origin (Kaur & Sekhon, 2012)
The FDA currently has 3677 studies regarding the effectiveness and safety of digestive
enzymes (Clinical Trials, n.d). According Natural Medicines’ database, digestive enzyme’s level
of evidence is a grade C (unclear or conflicting scientific evidence) for digestive enzyme
insufficiency, hiatal hernias, and recovery from surgery (pancreatic, gastrectomy) (Natural
Standards, 2015c). At Atlanta Center for Holistic and Integrative Medicine the most common
digestive enzymes utilized in the restoring digestive health protocol are called GFCF Similase.
This digestive enzymes is a purely plant based product that consists of protease I, II, III, IV, V,
amylase, lipase I, II, phytase, lactase I, II, cellulose I, II, and sucrase. However, there are several
other digestive enzymes available on the market including bromelain sources or betaine HCL.
The specific digestive enzymes used in this study are not metabolized by the CYP 450 system;
therefore they do not interact with medications that are metabolized by the CYP 450 system.
Age
Patient age range most affected by Functional Gastrointestinal Disorders remains vague
and inconsistent. Research studies have found a wide-range of ages affected from childhood to
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adulthood. A case-control study of 23,471 diagnosed with Functional Gastrointestinal Disorders
was conducted in the United Kingdom. The mean age for this study was 51.4 years old (Ford et
al., 2014). A study examined the prevalence of Functional Gastrointestinal Disorders among
3,976 adolescents (10-17 years old) from 40 different schools. The study found that 552 students
met the criteria for Functional Gastrointestinal Disorders. Although this study was conducted on
adolescents, the results showed that the prevalence of Functional Gastrointestinal Disorders
significantly increased as the adolescents aged (Sagawa et al., 2013). A European study
examined 199 patients with Functional Gastrointestinal Disorders and found the mean age to be
50 years old, ranging from 21-85 years old (Lahner et al., 2013). Another study examined 3,600
individuals with Functional Gastrointestinal Disorders (Ford et al., 2014). The mean age for
irritable bowel syndrome, functional diarrhea, and chronic idiopathic constipation was 38-42
years old, 48 years old, and 52 years old respectively (Ford et al., 2014). Other studies have
found that individuals younger than 50 years old are affected by irritable bowel syndrome more
frequently (Scalera & Loguercio, 2012). As evident by the supporting studies, Functional
Gastrointestinal Disorders do not discriminate, affecting all ages.
Gender
Functional Gastrointestinal Disorders affect females more frequently than males, yet the
etiology behind this remains unknown (Markert et al., 2014). Possible theories for the female
predominance include hormonal variations and perceived stress. Ford et al. (2014) found females
to suffer more frequently from Functional Gastrointestinal Disorders including irritable bowel
syndrome, functional dyspepsia, and chronic idiopathic constipation. In Western countries,
irritable bowel syndrome is more common in females with a one to three ratio of males to
females (Scalera & Loguercio, 2012). One study found women to have a 20% higher rate of
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ambulatory visits related to gastrointestinal symptoms than men (Myer et al., 2013). A study
conducted on adolescent found females to have a significantly higher prevalence of Functional
Gastrointestinal Disorders compared to male students (Sagawa et al., 2013).
In contrast, an epidemiological study was conducted in Mexico to determine the
prevalence of Functional Gastrointestinal Disorders. This study found that all Functional
Gastrointestinal Disorders were equally prevalent among both genders except for irritable bowel
syndrome and functional constipation which were found to be more prevalent in women (LópezColombo et al., 2012). A large Internet survey was conducted in Japan to evaluate the lifestyle of
individuals suffering with Functional Gastrointestinal Disorders (Miwa, 2012). The results of
this study showed that the prevalence of functional dyspepsia and irritable bowel syndrome were
significantly higher in women than males (Miwa, 2012). A study conducted on 31,866 U.S
military personnel diagnosed with Functional Gastrointestinal Disorders found an overall higher
incidence of Functional Gastrointestinal Disorders among females compared to males (Porter et
al., 2011). Specifically, this study found a seven-fold higher rate of functional constipation
among females compared to males (Porter et al., 2011). The case-control study conducted in the
United Kingdom found a higher prevalence of females diagnosed with Functional
Gastrointestinal Disorders (66.1%) (Ford et al., 2014). Another study conducted in Europe,
found a female predominance (75.9%) when assessing 199 individuals with Functional
Gastrointestinal Disorders (Lahner et al., 2013).
Ethnicity
There are limited studies assessing the role ethnicity plays on Functional Gastrointestinal
Disorders. One study found that there were not any significant differences in ambulatory visits
related to gastrointestinal symptoms between Caucasians and African Americans (Myer et al.,
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2013). Ford et al. (2014) found the majority of irritable bowel syndrome (87.4%) and chronic
idiopathic constipation (88.9%) patients to be Caucasians.
Weight and Waist Circumference
The majority of the studies related to Functional Gastrointestinal Disorders, found that
individuals that are overweight or obese suffer from Functional Gastrointestinal Disorders
symptoms more frequently. A study was conducted on 450 children with 42% overweight or
obese and 58% normal weight (Phatak & Pashankar, 2014). The results of this study found that
in children, obese and overweight participants (47%) had a higher prevalence of Functional
Gastrointestinal Disorders than normal-weight children (27%) (Phatak & Pashankar, 2014). A
study conducted on 199 European adults diagnosed with Functional Gastrointestinal Disorders
found the average body mass index to be 39.2, which is considered class II obesity (Lahner et al.,
2013).
An increased weight circumference is associated with an increased risk of irritable bowel
syndrome (Lee et al., 2015). A descriptive study was conducted in Turkey to evaluate how
obesity affects gastrointestinal quality of life (Yilmaz, 2013). The results of this study found that
obese patients suffer from gastrointestinal symptoms more frequently and have a decreased
quality of life based on the Gastrointestinal Quality of Life Index (Yilmaz, 2013).
A prospective cohort study examined 35,447 adults to examine the relationship between
BMI and Functional Gastrointestinal Disorders (Le Pluart et al., 2015). This study found that
females with a high BMI had a significantly increased risk for functional diarrhea; however both
high and low BMIs were shown to have an increased risk for functional dyspepsia (Le Pluart et
al., 2015). In men, those with a lower BMI were found to have a greater risk for irritable bowel
syndrome (Le Pluart et al., 2015). A smaller case-controlled study with 336 individuals found
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that overall BMI was not a good predictor for irritable bowel syndrome; yet, abdominal fat and
an increased waist circumference were better predictors of irritable bowel syndrome, specifically
irritable bowel syndrome with diarrhea (Lee et al., 2015).
Quality of Life
Several studies have been conducted to examine the correlation of Functional
Gastrointestinal Disorders symptoms and quality of life. Adolescents suffering from Functional
Gastrointestinal Disorders had a significantly lower quality of life score (Sagawa et al., 2013).
Individuals suffering from Functional Gastrointestinal Disorders were shown to have
impairments in sleep, eating habits, diet, exercise, and feelings of excessive stress (Miwa, 2012).
A random sample of 1,001 Swedish adults was conducted to assess the impact functional
dyspepsia has on quality of life (Aro et al., 2011). This study used the Short Form-36
questionnaire to assess eight domains related to quality of life including physical, mental, and
social aspects (Aro et al., 2011). The results of this study found a statistically significant impact
on health-related quality of life (p < .05) in all the Short Form-36 domains except for Role
Emotional (Aro et al., 2011).
Singh et al. (2012) conducted a study to examine the prevalence of somatic and
psychiatric co-morbidities seen in patients with irritable bowel syndrome and how the disorder
affects the participants’ quality of life. The study evaluated 184 participants diagnosed with
irritable bowel syndrome and 198 controlled participants. Major depressive disorders,
somatoform disorders, and panic disorders were more common in patients suffering from
irritable bowel syndrome than in the controls (Singh et al., 2012). Quality of life was
significantly lower in patients with irritable bowel syndrome when compared to the control
group based on the World Health Organization (WHO) QOL-BREF (Singh et al., 2012).
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Lackner et al. (2014) conducted a study with 234 individuals with irritable bowel
syndrome to determine what factors reduced the individual’s quality of life. The results of this
study found that fear of gastrointestinal symptoms related to irritable bowel syndrome was the
most strongly associated with reduced quality of life (Lackner et al., 2010; Lackner et al., 2014).
This factor was shown to triumph other factors, such as symptom severity, personality,
sociodemographics, and overall emotional wellbeing (Lackner et al., 2010.; Lackner et al.,
2014).
Stress
Those suffering from Functional Gastrointestinal Disorders are thought to have higher
stress levels. Markert et al. (2014) conducted a study on two different universities in Switzerland
to evaluate the association between stress and digestive symptoms. A total of 1901 participants
completed the survey online with 1857 participants included in the study. Of the sample, 62.78%
met the criteria for at least one Functional Gastrointestinal Disorders. The results of this study
found that those with higher levels of self-reported stress had worse symptoms (Markert et al.,
2014).
Another study was conducted on 105 patients diagnosed with irritable bowel syndrome to
examine the association between social support and the severity of irritable bowel syndrome
(Lackner et al., 2010). The Perceived Stress Scale was used to measure how the participants
appraised the amount of stress in their life. This study found that perceived stress significantly
predicted pain severity (p < 0.05) (Lackner et al., 2010).
Duration of Symptoms
When conducting the literature review, minimal information was obtained regarding the
mean duration of Functional Gastrointestinal Disorder symptoms. However, the majority of the
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studies used the diagnosis of Functional Gastrointestinal Disorders as having experienced
functional symptoms involving the upper and/or lower gastrointestinal tract over the past 6
months at least one time per week (Lahner et al., 2013).
Number of Attempted Treatments
Conventional or standard treatment for functional gastrointestinal disorders is symptom
management through laxatives, antidiarrheal, antispasmodics, or antidepressants. It is estimated
that less than 50% of patients with irritable bowel syndrome are satisfied with their treatment
plan (Aucoin, 2014). Therefore, 21-51% of irritable bowel syndrome patients are seeking
complementary and alternative modalities (Aucoin, 2014). Historically, treatment of Functional
Gastrointestinal Disorders focused on symptom relief through conventional medications.
However, symptom control has not been effective means for managing the symptoms associated
with Functional Gastrointestinal Disorders (Lahner et al., 2013).
Failure of conventional therapy may be related to the poorly understood pathology and
the vast psychological factors associated with Functional Gastrointestinal Disorders (Lahner et
al., 2013). Due to the lack of success with conventional therapy, individuals suffering from
Functional Gastrointestinal Disorders are beginning to try complementary and alternative
medicine therapies. A study was conducted on 199 patients diagnosed with Functional
Gastrointestinal Disorders to examine patients’ current treatment modalities for the management
of Functional Gastrointestinal Disorders (Lahner et al., 2013). The results show that roughly half
of the patients in the study used some sort of CAM (48.7%) including herbal medicine (36.7%)
and homeopathy therapy (17.1%) (Lahner et al., 2013). Natural remedies include a dietary
approach (64.3%), exclusion diets (39.7%), probiotics (31.7%), and prebiotics (22.6%). Twothirds of the patients used more than one treatment option for the management of symptoms:
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34.7% conventional medications, CAM, and dietary supplements, 17.1% conventional
medications and dietary supplements, 10.1% diet and CAM, and 5% conventional medications
and CAM (Lahner et al., 2013). When examining conventional medications, the largest drug
class utilized includes proton pump inhibitors (42.2%), antispasmodics (34.2%), anti-acids
(29.1%), and prokinetics (29.1%) (Lahner et al., 2013).
Theoretical Framework
Betty Neuman’s Healthcare System Model
Understanding the basic assumptions of Betty Neuman’s Healthcare System Model is
important when restoring digestive health. Betty Neuman’s Healthcare System Model stresses
the fact that each client’s system is unique; therefore, no two patients are created equal. Within
each system there are known, unknown, and universal stressors that occur within each client’s
life (Neuman, 1989). These stressors have the ability to disturb the client’s stability. The term
“wellness” can be thought of as a continuum with optimal wellness on one side and illness on the
other side. When caring for patients with functional gastrointestinal disorders, the goal is
optimizing their wellness and reducing their gastrointestinal symptoms. Individuals are
continuously shifting along the continuum depending on internal and external stressors.
Examples of internal stressors include anxiety and depression. External stressors include job
stress, family stress, and social stress. At times, food sensitivities or environmental triggers could
be aggravating gastrointestinal symptoms. Reducing known and unknown stressors can
ultimately improve the patient’s symptoms and healthcare outcomes.
Major concepts and terms explained in this theory include content, basic structure or
central core, degree to reaction, entropy, negentropy, open systems, stability, and stressors.
Content is the variables within each person’s interaction with the internal and external

RESTORING DIGESTIVE HEALTH

37

environment that comprise the whole person’s system (Neuman, 1989). In patients with
Functional Gastrointestinal Disorders, stress may be a variable that is compromising the whole
person’s system. The basic structure or central core is made up of the basic survival factors,
such as, temperature and genetic structures (Neuman, 1989). Patients with digestive dysfunction
have basic structures or survival factors embedded in their system to help overcome illnesses.
For example, if patients are exposed to bacteria via ingestion, the body’s natural mechanism is to
speed up motility to eliminate the bacteria. This can cause diarrhea or loose stools. Stability or
homeostasis is achieved when the energy that is available exceeds that being used by the system
(Neuman, 1989). This process is constantly changing to maintain a state of balance with input,
output, feedback, and compensation (Neuman, 1989). Stability or homeostasis is achieved in
patients with Functional Gastrointestinal Disorders when there is resolution of gastrointestinal
symptoms and balance is achieved. The degree to reaction is the amount of each system that is
unstable due to the negative impact of stressors (Neuman, 1989). In patients with Functional
Gastrointestinal Disorders the higher the degree of reaction, or the negative factors that cause the
system to become unstable, the worse the gastrointestinal symptoms become. Entropy is the
process of energy depletion and disorganization that ultimately moves the system towards illness
or in this case functional gastrointestinal disorder symptoms (Neuman, 1989). Negentropy is the
process of energy conservation that increases the organization and complexity of the system
(Neuman, 1989). This makes the system more stable allowing the body to achieve a higher
degree of wellness.
Neuman’s model relies heavily on the concept of an open system. An open system is
where all systems are in continuous interaction with each other and the environment (Neuman,
1989). In the human body, the digestive system interacts with numerous other systems including
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the pancreas, gallbladder, and liver. The term reconstitution is used when the system has
returned and maintained stability. Betty Neuman believes reconstitution is possible.
Reconstitution typically occurs after an individual has defined and reduced his or her individual
stressor. The end goal of Betty Neuman’s Theory is stability, which is a state of balance and
harmony. This is achieved when the patient adequately copes with stressors and maintains an
optimal level of health and wellness. Overtime, this preserves the systems overall integrity.
When considering Betty Neuman’s Healthcare System Model, it is important to
remember that each client’s system is in a state of dynamic and constant energy exchange with
the environment. Research suggests that internal and external stressors can worsen
gastrointestinal symptoms. As previously stated, internal stressors could be anxiety, emotional
stress, or physical illness. There is clear evidence that anxiety and depression are positively
correlated with abdominal pain (Walter et al., 2013). External stressors may be family illnesses,
job deadlines, or schoolwork. There are several promising treatment options for reducing these
stressors, such as mindfulness programs and cognitive behavior therapy. Studies have found that
mindfulness programs can improve irritable bowel syndrome symptoms (Kearney, McDermott,
Martinez, & Simpson, 2011). Mindfulness programs have the power to reduce the negative
effects of external and internal stressors. GI-specific anxiety has been used to describe thoughts,
emotions, and behaviors that revolve around the fear of developing gastrointestinal symptoms
(Kearney et al., 2011). This is an endogenous stressor that can worsen intestinal function and
cause visceral pain (Kearney et al., 2011). Research suggests that mindfulness training has been
shown to significantly reduce bowel symptom severity, improve health-related quality of life,
and reduce distress (Gaylord et al., 2011). The results found in this study showed that the
positive benefits persisted for 3 months after treatment with mindfulness training (Gaylord et al.,
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2011). Therefore, this is a cost-effective treatment with long lasting impact in the patients overall
health. Another study found that increased perception of social support improved irritable bowel
syndrome symptoms, specifically abdominal pain (Lackner et al., 2010). The social support
seemed to reduce stress levels and ultimately improve irritable bowel syndrome symptoms
(Lackner et al., 2010).
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CHAPTER III

Project Description and Methodology
Objectives
The specific aim of this project was to outline the healthcare problems associated with
Functional Gastrointestinal Disorders and to explore the effectiveness of a gastrointestinal
protocol implemented at Atlanta Center for Holistic and Integrative Medicine. This protocol was
designed to help restore digestive health.
The purpose of the proposed translational research project was to determine if adult
patients with Functional Gastrointestinal Disorders would report improved symptoms based on
the Gastrointestinal Quality of Life Index after eight weeks of probiotics, digestive enzymes, and
glutamine. Each one of the components of this intervention served a unique purpose. The
probiotics were used to help improve the bacterial gut morphology. The digestive enzymes
helped facilitate digestion and absorption of nutrients from food, which allowed the digestive
tract time to rest and heal. Glutamine was used to calm inflammation, improve intestinal
permeability, and heal the intestinal lining. The primary objective of this research project was to
quantify a well-established protocol utilized at the Atlanta Center for Holistic and Integrative
Medicine. This practice’s protocol focuses heavily on restoring digestive function, since a
normally functioning digestive tract is essential for overall health and wellbeing.
Project Design and Procedures
The design for this translational research project was a prospective cohort study. The
subjects in this study were examined at baseline, weekly, and after eight weeks of intervention
with probiotics, digestive enzymes, and glutamine. This design was appropriate to examine the
effectiveness of the restoring digestive health protocol in adults with gastrointestinal symptoms.
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Below is a brief overview of the project design. Each component will be further discussed in the
following sections. A flow diagram for the research study can be found under Appendix A.
Consent from Atlanta Center for Holistic and Integrative Medicine and Georgia College
and State University Institutional Review Board was obtained prior to beginning the recruitment
of participants for this study. After receiving IRB approval, the researcher enrolled subjects that
met the inclusion criteria. Recruitment was initiated in May 2015 from Atlanta Center for
Holistic and Integrative Medicine. The subjects were virtually recruited through ACHIM’s
newsletters and Facebook wall. An example of the flyer used in the newsletter and on Facebook
can be found under Appendix B. Participants that expressed interest in participating in the
research study received a detailed informed consent to his or her email. An example of the
informed consent can be found in Appendix C.
If the participants would like to participate after reading the full informed consent, the
consent was signed and either faxed or scanned directly to the researcher. The researcher
reviewed each informed consent to ensure the participant answered “no” to the alarming
symptoms based on the Rome III criteria. If a participant answered “yes” to any of the exclusion
criteria, they were not allowed to participant in the study. Once the informed consent was signed
and received by the researcher, the qualified participants received a welcome email with detailed
instructions for the research study. Each subject voluntarily participated with the ability to cancel
his or her participation at any time during the study without reason. Participants that lived close
to ACHIM had the option to personally pick up the supplements (probiotics, digestive enzymes,
and glutamine) and those that did not live close had the supplements mailed directly to his or her
house at the researcher’s expense.
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The welcome email included links to an introduction video, a video demonstrating how to
accurately measure weight and waist circumference, baseline questionnaires administered
through survey monkey and a study checklist. The introduction video clearly outlined the
purpose of the research study and an official thank you for his or her time and participation. The
video explained the expected time commitment, his or her rights to withdraw at any time, the
confidentiality in data collection, analysis and reporting of findings. The next video explained to
each participant the importance of consistency for weekly weigh-ins and waist circumference
measurements. The video outlined (step by step) how to accurately measure his or her waist
circumference and weight. An identification number was assigned to each participant prior to
starting data collection. All participants were prompted to put in their unique identification
number on each electronic questionnaire and weekly update. Only the principal investigator had
access to the participant’s identity and identification number. All information obtained was
encrypted and password protected on a secure network. The initial assessment questionnaire
included demographic data (age, gender, and ethnicity), duration of symptoms, number of
attempted treatments, waist circumference, weight, Perceived Stress Scale, and the
Gastrointestinal Quality of Life Index. The baseline questionnaire was completed prior to
starting the intervention of probiotics, digestive enzymes, and glutamine. The study checklist
could have been printed and kept as a reminder for each step during the research study. An
example of the study checklist can be found under Appendix D.
To enhance compliance and active involvement, each participant received a weekly email
through survey monkey. Survey monkey was used to collect the data because it has the ability to
automatically sync with SPSS version 22.0. The weekly questionnaire would prompt individuals
to enter their unique identification number prior to answering the four questions: (1) how many
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supplements did you miss in the previous week; (2) what is your current weight; (3) what is your
current waist circumference; and (4) any additional comments at this time. The purpose of the
weekly weight and waist circumference was to determine the timing of significant change,
minimize missed supplements, and encourage active participation. If participants missed more
than 2 weekly entries, their data was excluded. However, if a participant missed a Wednesday
survey the researcher sent two additional reminders to their email 24 hours apart. No participant
was penalized for missing supplements because research shows even individuals on crucial
medications can occasionally forget their daily dose. A study was conducted to assess how often
individuals with epilepsy forgot their medication (Paschal, Rush, & Sadler, 2014). The results of
the study found that 66% of the 180 subjects reported not taking their medication on a monthly
basis due to “forgetfulness” (Paschal et al., 2014).
After the 8-week intervention of probiotics, digestive enzymes, and glutamine, a postintervention questionnaire was administered through the participants preferred email. This email
included the Perceived Stress Scale, Gastrointestinal Quality of Life Index, waist circumference,
and weight. All data collected was analyzed to answer each specific research question and the
results were disseminated at the Georgia Nursing Leadership Coalition’s Doctorate Symposium
in November of 2015. All data was reported in aggregate to keep patient confidentiality.
Collected data will be kept on a secure network for five years.
Project Site
The researcher for this project is a Family Nurse Practitioner at Atlanta Center for
Holistic and Integrative Medicine, located in Atlanta, Georgia. This practice is a unique fee-forservice practice with three physicians, two nurse practitioners, a registered dietician, a
nutritionist, an acupuncturist and an Ayurveda therapist. The primary focus of the practice is to
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integrate both mainstream conventional medicine and alternative therapies to heal the whole
person and uncover the root cause of patients’ symptoms.
The Founder of the Center, Dr. Tasneem Bhatia was a committee member for this
translational research project. Letters of Support and the Statement of Mutual Agreement were
obtained from Atlanta Center for Holistic and Integrative Medicine prior to beginning the study.
Sample
From May to June 2015, a convenience sample was obtained from the Atlanta Center for
Holistic and Integrative Medicine (ACHIM). This practice sends out a virtual newsletter to over
5,000 people and it has a Facebook group with over 20,000 followers. Both the virtual newsletter
and Facebook group were used to recruit subjects. While the primary researcher of this project
works at ACHIM, she did not personally recruit patients to ensure participants did not feel
coerced to participate. All subjects voluntarily enrolled in the study. Approval from the
Institutional Review Board was obtained prior to recruiting subjects. Informed consent was
obtained from each participant prior to data collection.
Inclusion Criteria. Adult patients (males and females) 18 to 65 years old with current
complaints of gastrointestinal symptoms including, but not limited to constipation, abdominal
pain, diarrhea, reflux, or bloating. Digestive symptoms had to be functional without a known
organic cause. Each participant was required to have a physical exam within the 12 months of
the research study. Participants must have been proficient in English and have access to email, a
scale, and a tape measure (in centimeters). Each participant had to be able to follow directions.
Participants who were willing and able to participate in the full course of the study signed the
informed consent.
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Exclusion Criteria. Exclusion criteria included patients younger than 18 years old or
older than 65 years old, pregnant or nursing women, and any symptoms which may indicate
significant health related problems based on the alarming symptoms in the Rome III Criteria.
The primary researcher screened all participants based on the Rome III Criteria for alarming
symptoms. The alarming symptoms used from the Rome III Criteria include: blood in stool,
black stools, vomiting blood, anemia unrelated to menstrual cycle, fever, unintentional weight
loss of greater than 10 pounds, over the age of 50 with a major change in bowel movements,
persistent or worsening hoarseness of the voice, worsening throat pain over the past 3 months,
chest pain on exertion, and difficulty swallowing. Participants under 18 years old were excluded
from the study to avoid having to take into account growth and developmental factors. All
participants diagnosed with an organic gastrointestinal disease were excluded including peptic
ulcers, Crohn’s disease, ulcerative colitis, or gastrointestinal tumors. Any participants that selfreported diseases that alter the function of the liver or kidney were excluded from the study
including hepatitis, cirrhosis, non-alcoholic fatty liver disease, kidney disease, or organ
transplants.
Sample size. The sample size was determined based on Warner’s decision rule for
calculating sample sizes with a power of 0.80 and an alpha of 0.05 (Warner, 2008) to test
significance with R2 with a medium effect (F2-0.15) the total N required was 80 + k where k was
the number of independent variables. In this study, sample size was based on 10 independent
variables. Based on Warner’s formula, the sample size needed is 90 adult subjects with
functional gastrointestinal symptoms. This study had 98 enroll in the study and 86 complete the
entire 8-week intervention.
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Supplements
The specific brands used in the restoring digestive health protocol at Atlanta Center for
Holistic and Integrative Medicine include Metagenics, Integrative Therapeutics, and
Orthomolecular. The same brands were used for this study for a number of reasons including the
following: (a) to replicate the protocol as closely as possible; (b) to keep consistency among each
participant; (c) to ensure the high quality supplements were used. The following products were
donated for the research study: Glutagenics by Metagenics (glutamine powder), Orthobiotic by
Orthomolecular (probiotic), GFCF Similase by Integrative Therapeutics (digestive enzymes).
Since the products were donated, the study was free for participants. The researcher received no
compensation by the companies and does not promote specific brands.
Instruments
The instruments utilized in this study include the Gastrointestinal Quality of Life Index,
the Perceived Stress Scale, weight, and waist circumference. The following section discusses
these instruments.
Gastrointestinal Quality of Life Index. Defining distress is often difficult because it is a
subjective term. Researchers often validate distress by quantifying and measuring the patients’
quality of life through appropriate instruments, such as the Gastrointestinal Quality of Life Index
(GQOLI) as used in this study. It is evident that there is a direct correlation between
gastrointestinal symptoms and quality of life (Naliboff et al., 2012; Tielemans et al., 2013).
Unfortunately, there is limited research investigating the impact of subjective distress and
Functional Gastrointestinal Disorders (Markert et al., 2014). The instrument utilized in this
translation research project was the Gastrointestinal Quality of Life Index (Eypasch et al., 1995).
Prior to using this tool, permission was obtained via email from the instrument’s designer. The
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Gastrointestinal Quality of Life Index was developed in 1995 by 4 surgeons and 3
methodologists (Eypasch et al., 1995). This instrument was developed to help healthcare
providers better measure quality of life specific for the gastrointestinal tract. The GIQLI is a 36Likert item GI-specific Health Related Quality of Life (HRQL) instrument designed to assess
HRQL in clinical practice and clinical trials of patients with gastrointestinal disorders (Eypasch
et al., 1995). The GIQLI has five sub scales (Gastrointestinal symptoms, Emotion, Physical
Function, Social Function, and Medical Treatment) as well as a total score (Eypasch et al., 1995).
Each of the items was scored on a five point Likert scale with a range from 0 (most negative) to
4 (most positive). Possible total scores ranged from 0-144 points (Eypasch et al., 1995). The
Intraclass Correlation Coefficient (ICC) was .92 which denotes a high level of reliability and the
internal consistency based on Cronbach’s Alpha ranged from .90 to .93 (Eypasch et al., 1995).
This instrument has been used and validated in a variety of cultures.
In the United States, a study was conducted to evaluate gastrointestinal symptoms in liver
transplant patients after the conversion from mycophenolate mofetil to enteric-coated
mycophenolate sodium (Toledo et al., 2012). The GIQLI was administered to the participants at
baseline and three months later. The instrument was able to capture significant improvements
from baseline to three months in gastrointestinal quality of life (p < .05) (Toledo et al., 2012).
However, this article did not report the internal consistency.
A pilot study was conducted in the United States to assess the quality of life in pediatric
patients after a laproscopic cholecystectomy for biliary dyskinesia (Maxwell, Thompson,
Richmond, McCagg, & Ubert, 2012). This study administered the GIQLI to both the parents and
children. The results were similar between the parents and the children indicating homogeneity (r
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= .93) (Maxwell et al., 2012). The study found those patients suffering from long-term
symptoms have lower quality of life than those with symptom resolution (Maxwell et al., 2012).
Machnicki et al. (2008) conducted a longitudinal, observational study involving five
South American centers. The purpose of this study was to evaluate the reliability and validity of
two different GI-specific outcome measures (Gastrointestinal Symptom Rating Scale (GSRS)
and Gastrointestinal Quality of Life Index) in renal transplant patients. Each participant
completed the GSRS, GIQLI, and Psychological General Well-Being Index at baseline and at 4 –
6 weeks. The GIQLI total and sub scale scores demonstrated excellent internal consistency
reliability (.78 - .96) (Machnicki et al., 2008).
Borgaonkar & Irvine (2000) conducted a thorough literature review to evaluate ways to
reliably measure quality of life as it relates to gastrointestinal and liver disorders. The results of
the literature review found the GIQLI to be both valid and reliable. Construct validity was
supported by demonstrating a reasonable correlation with the Spitzer quality of life index (r =
.53) and the Bradburn aVect balance scale (r = .42) in 204 German patients with a variety of GI
illnesses (Borgaonkar & Irvine, 2000). The test-retest reliability was found to be excellent with
an ICC of .92 as was internal consistency (

> .90) (Borgaonkar & Irvine, 2000).

A study was conducted in the Netherlands to validate the GIQLI for patients with
periampullary tumors (van Dijkum et al., 2000). The GIQLI has been shown to be valid and
reliable based on the Cronbach’s alpha of each sub-score including, total score (.93), physical
well-being (.91), gastrointestinal digestion (.83), gastrointestinal defecation (.75), and mental
well-being (.87) (van Dijkum et al., 2000).
Sandblom et al. (2009) validated a Swedish version of the GIQLI in patients with
gallstones. The purpose of this study was to evaluate the sensitivity to change, internal
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consistency, and test–retest stability of the instrument on 187 consecutive patients who
underwent planned cholecystectomy (Sandblom et al., 2009). Construct validity was assessed by
comparing the GIQLI score with the SF-36 in a separate group of patients. The intraclass
correlation was .85 (95% CI [.73–.92]) for the global score, .87 (95% CI [.76–.93]) for
symptoms, .83 (95% CI [.70–.91]) for physical dysfunction, .68 (95% CI [.46–.81]) for
emotional dysfunction, .63 (95% CI [.40–.79]) for social dysfunction, and .62 (95% CI [.38–.78])
for effect of medical treatment (Sandblom et al., 2009). The Cronbach’s alpha was .92 for the
global score, .89 for symptoms, .84 for physical dysfunction, .83 for emotional dysfunction, and
.77 for social dysfunction (Sandblom et al., 2009). Therefore, the Swedish version of the GIQLI
was shown to be valid, reliable, and sensitive enough to yield significant results (p < .05)
(Sandblom et al., 2009).
Chen et al. (2005) conducted a study to evaluate the quality of life in patients who
underwent laparoscopic versus open cholecystectomy. Each participant completed the GQLI
preoperatively and at 2, 5, 10, and 16 weeks postoperatively (Chen et al., 2005). This instrument
was shown to be a valid and reliable way to detect significant changes (p < 0.05) in
gastrointestinal-specific quality of life after surgery (Chen et al., 2005).
Perceived Stress Scale. The Perceived Stress Scale (PSS) is a self-reported questionnaire
designed to measure the degree to which a person perceives a given situation as markedly
stressful compared to the individual’s ability to cope (Cohen, Kamarck, & Mermelstein, 1983).
The primary goal of the instrument is to provide a global and subjective way to measure
perceived stress (Cohen et al., 1983) and to assess the general predisposition an individual may
have to experience stress (Morgan, Umberson, & Hertzog, 2014). This instrument has been
described as the most popular measure for perceived stress (Karam et al., 2012). The PSS has
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been translated into over twenty-five languages including Arabic, Swedish, Spanish, Chinese,
Japanese and Turkish versions (Andreou et al., 2011; Taylor, 2014). Currently, there are three
versions of the PSS: the original 14-item scale (PSS-14), the 10-item scale (PSS-10), and the 4item scale (PSS-4) (Taylor, 2014).
In previous studies, the PSS-14 was shown to have good internal consistency with a
Cronbach alpha of .86 (Cohen et al., 1983). Through further investigating, the developers of the
PSS-14 found four of the items to be poor indicators of perceived stress and created the more
widely used and researched PSS-10 (Taylor, 2014). The PSS-10 is a 10-item Likert-type scale
with answers ranging from 0 - 4 (0 = never, 1 = almost never, 2 = sometimes, 3 = fairly often, 4
= very often) (Barbosa-Leiker et al., 2013; Taylor, 2014). Number 4, 5, 7, and 8 are reversescoring items (Taylor, 2014). Total scores are calculated after reversing positive items scores
ranging from 0 - 40, with higher scores indicating greater perceived stress.
The scale was first shown to be reliable when it was tested on a sample of college
students in comparison to the life-event scores (Cohen et al., 1983). The results presented
showed that the PSS was a better predictor of the outcomes related to stress than the life-event
scores (Cohen et al., 1983). The results of the PSS were further strengthened with the correlation
of elevated cortisol levels with higher PSS scores (Ezzati, 2013). Through the initial testing of
the PSS, the internal consistency reliability coefficients for the negative subscale of PSS-14,
PSS-10, and PSS-4 were .83, .83, and .67, respectively and the positive subscales of PSS-14,
PSS-10, and PSS-4 were .86, .81, and .71, respectively. The total scores of the PSS-14 and PSS10 had similar internal consistencies with a Cronbach’s alpha of .83 and .82 respectively,
however the PSS-4 was not found to be reliable with a Cronbach’s alpha of .68 (Andreou et al.,
2011; Cohen et al., 1983).
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The scale was further assessed on healthy adults and found an adequate reliability with
Cronbach’s alpha of .78 (Barbosa-Leiker et al., 2013). Another study found the PSS-10 to be a
reliable tool when measuring perceived stress in pregnant women taking anti-depressants with a
Cronbach’s alpha of .90 (Karam et al., 2012). Another study was seeking to validate the Swedish
version of the PSS-10; the results showed that the PSS-10 presents normally distributed data,
good internal reliability (

= .84), and good construct validity with anxiety (r = .68), depression

(r = .57), and mental and physical exhaustion (r = .71) (Nordin, 2013). Being that Nordin (2013)
studied the reliability and validity of the PSS-10 twenty-five years after its development and with
a different culture and still found comparable results, indicates that the PSS-10 is not culturesensitive rather it assesses the basic human reaction to stressful life events (Nordin, 2013). This
instrument is broad and can be applied to a platitude of situations. It has been used as both an
outcome variable and a predictor variable (Morgan et al., 2014).
For the purpose of this study, the PSS-10 was used. As outlined, this instrument has been
shown to be reliable and valid. It has been heavily researched in many different cultures and has
few limitations. One identified limitation, which would be true to all instruments that measure
stress is the gender bias. Females have been shown to have an overall higher level of stress than
males, which may skew the results (Taylor, 2014).
Weight. Each subject was required to have access to a scale and was asked to use that
same scale over the eight-week period. Weights were recorded at baseline, weekly, and postintervention. Since each participant was weighing him or herself on a weekly basis, each scale
was not calibrated. To enhance validity each participant received detailed instructions on how to
accurately measure his or her weight. The most important factor when gathering accurate weight
measurements was consistency. Therefore, each participant weighed his or herself on
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Wednesday with the same scale, without clothing, and at the same time of the day. Wednesdays
were chosen to prevent fluctuations in weight from the weekend.
Jerome et al. (2014) conducted a longitudinal study to assess the accuracy of web-based
self-reported weights. Each participant in the study received a digital scale for home use and
instructions to weight themselves at the same time of day, in the same clothing, and with the
same scale. The results of this study found that weight was significantly underestimated from 6
months to 24 months (Jerome et al., 2014).
Another study was conducted to validate self-reported weights and heights in avoiding
diabetes after pregnancy (Paez, Griffey, Thompson, & Gillman, 2014). Each participant was
mailed a digital scale with spare batteries and a printed protocol with weighing instructions. The
women were instructed to weigh themselves in the morning before eating, drinking, or dressing.
Scales were to be placed on a hard surface and calibrated by stepping on the scale and waiting
for it to blink three times (Paez et al., 2014). The results found that the women under-reported
their weight (Paez et al., 2014).
Waist Circumference. Waist circumference was self-reported at baseline, weekly, and
post-intervention. Each participant was required to watch the instructional video on how to
accurately measure waist circumference prior to starting the study. For the purpose of the study,
each waist circumference was measured (in centimeters) in line with the umbilicus and parallel
to the floor. Participants were instructed to take two measurements back to back and report the
average. Measurements were taken flush against bare skin, at the same time of the day, every
Wednesday over the course of the study. Wednesdays were chosen to prevent fluctuations in
weight from the weekend.
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A study was conducted to assess the validity of self-reported waist circumference
measurements in Thai adults (Lim, Seubsman, Sleigh, & Bain, 2012). The results of the study
found self-reported waist circumference to be similar to the technicians waist circumference
measurement with a concordance correlation coefficient from .84 to .90 (Lim et al., 2012). This
study had subjects measure their waist circumference at the umbilicus with light clothing on
(Lim et al., 2012).
Another study was conducted to assess the validity of self-measured waist circumference
in adults at risk of type 2 diabetes and cardiovascular disease (Ayala, Nijpels, & Lakerveld,
2014). In this study, each participant received mailed instructions and a measuring tape. The
instructions specified that the waist circumference should be taken around a bare belly just above
the navel (Ayala et al., 2014). The results of this study found that participants on average overestimated their waist circumference (Ayala et al., 2014).
Dekkers, van Wier, Hendriksen, Twisk, and van Mechelen (2008) conducted a study to
assess the accuracy of self-reported body weight, height, and waist circumference in a Dutch
overweight working population. The instructions were mailed to each participant along with a
questionnaire. Participants were instructed to use a non-stretchable paper measuring tape to
measure their waist circumference in centimeters. Subjects were instructed to measure their waist
circumference at the mid-point between the lower border of the ribs and the upper border of their
pelvis. Participants were advised to measure against bare skin during exhalation with feet 25-30
cm apart. Subjects were to take two measurements back to back and report the average value
(Dekkers et al., 2008). Waist circumference was significantly over-reported by an average of 1.1
cm (Dekkers et al., 2008).
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Research Questions
The specific aim of this project was to determine if adult patients suffering from
Functional Gastrointestinal Disorders would report improved symptoms based on the
Gastrointestinal Quality of Life Index after 8 weeks of probiotics, digestive enzymes, and
glutamine. This specific gastrointestinal protocol is heavily used at Atlanta Center for Holistic
and Integrative Medicine. Below is a list of the clinical questions examined.
Pre-Intervention Clinical Questions
1. What demographic factors (age, gender, ethnicity, duration of symptoms, and number of
attempted treatments) are associated with a lower level of gastrointestinal quality of life?
2. What is the association between patients’ perceived stress and gastrointestinal quality of
life?
3. Controlling for demographic variables (age, gender, ethnicity, duration of symptoms, and
number of attempted treatments) what is the association of perceived stress on
gastrointestinal quality of life?
4. What demographic factors (age, gender, ethnicity, duration of symptoms and number of
attempted treatments) are associated with an increased weight and weight circumference?
5. Controlling for demographic variables (age, gender, ethnicity, duration of symptoms, and
number of attempted treatments), what is the association between perceived stress and
waist circumference and weight?
6. Controlling for demographic variables (age, gender, ethnicity, duration of symptoms, and
number of attempted treatments), is there an association between gastrointestinal quality
of life and weight and waist circumference?
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Post-Intervention Clinical Questions
7. After 8-week treatment with probiotics, digestive enzymes, and glutamine, is there an
association between patients' perceived stress and gastrointestinal quality of life?
8. Controlling for demographic variables (age, gender, ethnicity, duration of symptoms, and
number of attempted treatments) after 8-week treatment with probiotics, digestive
enzymes, and glutamine what is the association of perceived stress on gastrointestinal
quality of life?
9. Controlling for demographic variables (age, gender, ethnicity, duration of symptoms, and
number of attempted treatments) after 8-week treatment with probiotics, digestive
enzymes, and glutamine, what is the association between perceived stress and waist
circumference and weight?
10. Controlling for demographic variables (age, gender, ethnicity, duration of symptoms, and
number of attempted treatments) after 8-week treatment with probiotics, digestive
enzymes, and glutamine, what is the association between gastrointestinal quality of life
and weight and waist circumference?
11. After 8-week treatment with probiotics, digestive enzymes, and glutamine, is there a
statistically significant change in the gastrointestinal quality of life, weight, waist
circumference, and perceived stress?
Dissemination
The author of this research study disseminated the findings with a podium presentation at
a conference at West Georgia College in November 2015. Understanding the importance of
dissemination, the author of this research study plans to apply for publication in a variety of
medical journals.
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Data Analysis

The collected data was analyzed using Statistical Package for the Social Sciences (SPSS)
software version 22.0. Data analysis began with an examination of missing data and standard
data cleaning. Internal consistency reliability of all the instruments was determined for this
sample. All interval/ratio variables were assessed for normality and measures of central
tendency. Descriptive statistics were used to describe the demographics of the sample. Any
instrument that was not completed fully by the participant was not used in the final analysis if
greater than 20% of the data was missing. If less than 20% of the data on a single scale was
missing, the mean sample replacement was used to replace the missing data. Statistical
assumptions for all statistical tests were examined prior to addressing the research questions.
Analysis Plan for Research Questions
Research Question One: What demographic factors (age, gender, ethnicity, duration of
symptoms, and number of attempted treatments) are associated with a lower level of
gastrointestinal quality of life?
Approach: Appropriate statistical analysis was selected depending on the level and normality
of the data. Both age and gastrointestinal quality of life scores were normally distributed and
interval/ratio level data, therefore Pearson’s correlational analysis was used to evaluate whether
age was associated with a lower level of gastrointestinal quality of life. An independent samples
t-test was used to test the association between gender, ethnicity, duration of symptoms, and
number of attempted treatments and gastrointestinal quality of life.
Research Question Two: What is the association between participants’ perceived stress and
gastrointestinal quality of life?
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Approach: Perceived stress was measured by the Perceived Stress Scale and gastrointestinal
quality of life was measured by the Gastrointestinal Quality of Life Index. Both of these
instruments were interval/ratio level data and normally distributed. Therefore, Pearson’s
correlational coefficient was used to determine if there was an association between participants’
perceived stress and gastrointestinal quality of life.
Research Question Three: Controlling for demographic variables (age, gender, ethnicity,
duration of symptoms, and number of attempted treatments) what is the association of perceived
stress on gastrointestinal quality of life?
Approach: A simultaneous multiple linear regression was conducted to test the relationship
between age, gender, ethnicity, duration of symptoms, number of attempted treatments, and
perceived stress on gastrointestinal quality of life after controlling for the independent variables.
Research Question Four: What demographic factors (age, gender, ethnicity, duration of
symptoms and number of attempted treatments) are associated with an increased weight and
weight circumference?
Approach: Appropriate statistical analysis was selected depending on the normality and level
of data. Initially, all of the interval/ratio level data was normally distributed except for weight.
After conducting a logarithm transformation, weight was normally distributed based on Fisher’s
measure of skewness and kurtosis. Therefore, the association between age on weight and waist
circumference was examined with Pearson’s correlational coefficient. Ethnicity, duration of
symptoms, and number of attempted treatments was grouped and coded dichotomously.
Therefore, the association between gender, ethnicity, duration of symptoms, and number of
attempted treatments on waist circumference/weight was tested with an independent t-test. The

RESTORING DIGESTIVE HEALTH

59

association between duration of symptoms and number of attempted treatments on weight and
waist circumference was verified with a one-way ANOVA.
Research Question Five: Controlling for demographic variables (age, gender, ethnicity,
duration of symptoms, and number of attempted treatments), what is the association between
perceived stress and waist circumference and weight?
Approach: A simultaneous multiple linear regression was conducted to test the relationship
between age, gender, ethnicity, duration of symptoms, and number of attempted treatment on
perceived stress and waist circumference/weight after controlling for the independent variables.
Research Question Six: Controlling for demographic variables (age, gender, ethnicity,
duration of symptoms, and number of attempted treatments), is there an association between
gastrointestinal quality of life and weight and waist circumference?
Approach: A simultaneous multiple linear regression was conducted to test the relationship
between age, gender, ethnicity, duration of symptoms, and number of attempted treatments on
gastrointestinal quality of life and waist circumference/weight after controlling for the
independent variables.
Research Question Seven: After 8-week treatment with probiotics, digestive enzymes, and
glutamine, is there an association between perceived stress and gastrointestinal quality of life?
Approach: Perceived stress was measured with the Perceived Stress Scale and
gastrointestinal quality of life was measured with the Gastrointestinal Quality of Life Index. Both
of these instruments were interval/ratio level data and normally distributed. Therefore, Pearson
correlational coefficient was used to determine if there was an association between participants’
perceived stress and gastrointestinal quality of life.
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Research Question Eight: Controlling for demographic variables (age, gender, ethnicity,
duration of symptoms, and number of attempted treatments) after 8-week treatment with
probiotics, digestive enzymes, and glutamine, is there an association between perceived stress
and gastrointestinal quality of life?
Approach: A simultaneous multiple linear regression was conducted to test the relationship
between age, gender, ethnicity, duration of symptoms, number of attempted treatments, and
perceived stress on gastrointestinal quality of life after controlling for the independent variables.
Research Question Nine: Controlling for demographic variables (age, gender, ethnicity,
duration of symptoms, and number of attempted treatments) after 8-week treatment with
probiotics, digestive enzymes, and glutamine, what is the association between perceived stress
and waist circumference and weight?
Approach: A simultaneous multiple linear regression was conducted to test the relationship
between age, gender, ethnicity, duration of symptoms, number of attempted treatments, and
perceived stress on waist circumference/weight after controlling for the independent variables.
Research Question Ten: Controlling for demographic variables (age, gender, ethnicity,
duration of symptoms, and number of attempted treatments) after 8-week treatment with
probiotics, digestive enzymes, and glutamine, what is the association between gastrointestinal
quality of life and weight and waist circumference?
Approach: A simultaneous multiple linear regression was conducted to test the relationship
between age, gender, ethnicity, duration of symptoms, number of attempted treatments, and
gastrointestinal quality of life on waist circumference/weight after controlling for the
independent variables.
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Research Question Eleven: After 8-week treatment with probiotics, digestive enzymes, and
glutamine, is there a statistically significant change in the gastrointestinal quality of life, weight,
waist circumference, and perceived stress?
Approach: A paired samples t-test was used to evaluate whether there was significant
changes in gastrointestinal quality of life, weight, waist circumference, and perceived stress after
8-weeks of probiotics, digestive enzymes, and glutamine.
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CHAPTER IV
Results

The results of this prospective cohort study examine the effects of probiotics, digestive
enzymes, and glutamine on restoring digestive health in participants suffering from Functional
Gastrointestinal Disorders. Findings reported here include descriptive information concerning the
participants, reliability of the instruments, and data addressing the research questions.
Data
Data screening was performed prior to conducting the statistical analysis. All data was
verified using a double entry method where two separate databases were created and compared.
Any discrepancies were reconciled with the participants’ original data. Examination of all
continuous variables was conducted to determine distribution using descriptive statistics for
central tendency and Fisher’s exact for skewness and kurtosis. The weekly surveys were
examined and no participant missed more than three supplements per week.
The study’s instruments were examined for missing data. When participant’s had less
than 20% of the scores missing on the perceived stress scale and gastrointestinal quality of life
index, the sample means were substituted for those missing items (Shrive, Stuart, Quan, & Ghali,
2006). In this research study no participant missed greater than 20% of the data in the Perceived
Stress Scale (n = 0) or Gastrointestinal Quality of Life Index (n = 0). In the pre-intervention
survey, the following measures were missing age (n = 1), weight (n = 1), waist circumference (n
= 9), and duration of symptoms (n = 1). Since these variables are not part of a total score, the
missing variables were left missing.
Prior to answering the research questions, the variables were analyzed to see if they met
the assumptions for an ANOVA and linear regression. Instead of including both weight and
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waist circumference, only waist circumference was used to answer the clinical research questions
and regressional analyses for a number of reasons: (1) waist circumference was normally
distributed based on Fisher’s exact skewness statistic (2.13) and kurtosis (.44) (Munro, 2005), (2)
waist circumference is a better indicator of bloating, and (3) waist circumference was strongly
correlated with weight (r = 0.76, p < .001).
Weight was not normally distributed based on Fisher’s exact skewness statistic (3.71) and
kurtosis (.44) (Munro, 2005; Tabachnick & Fidell, 2006). Analysis of the data indicated that no
values were three standard deviations from the mean; therefore no outliers were removed (Kim
& Mallory, 2014). A statistical correction using an inverse natural logarithm was performed on
the variable as recommended by Tabachnick & Fidell (2006). After conducting the inverse
natural logarithm weight was normally distributed based on Fisher’s exact skewness statistic
(2.28) and kurtosis (1.13). The resulting mean was 2.17 (SD = 0.98).
Duration of symptoms was initially divided into five different categories including: less
than 1 year, 1-3 years, 4-6 years, 7-10 years, and greater than 10 years. In order to further
analyze the data, the results were divided into two groups: those who have had symptoms less
than 3 year and those that have had symptoms longer than 3 years. All analyzes were run using
the data grouped as less than 3 years and longer than 3 years to meet the assumptions of the
regression.
The number of attempted treatments was initially divided into four categories including:
no treatment, 1-2 different treatments, 3-5 different treatments, and greater than 5 treatments. To
further analyze the data, the results were divided into two groups: those who have attempted less
than 3 different treatments and those that have attempted more than 3 different treatments. All
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analyzes were run using the data grouped as less than 3 different treatments and more than 3
different treatments to meet the assumptions of the regression.
Ethnicities were divided into two categories including minorities and Caucasians.
Hispanic (n = 5) and Native American (n = 2) participants were included in the minority group
with African Americans due to the small number of participants.
The other variables including age, perceived stress, and gastrointestinal quality of life
were normally distributed in this sample based on Fisher’s exact. Each participant made his or
her own independent appraisal of their symptoms, all participants were mutually exclusive, and
the Levene tests were not significant indicating homogeneity of the variances of the participants
on the dependent variables (Munro, 2005).
Pre-Intervention Sample Characteristics
The initial sample consisted of 98 adult participants suffering from Functional
Gastrointestinal Disorders. The participants were recruited through Atlanta Center for Holistic
and Integrative Medicine’s social media including Facebook and blogs. Each participant
voluntarily enrolled in the study and was screened based on the inclusion and exclusion criteria.
Informed consent was obtained on each participant prior to initiating the study.
The initial study participants, as shown in Table 1, were 90.8% female (n = 89) and
primarily Caucasian (n = 76). Prior to starting the study, the majority of participants had tried no
more than five different treatment modalities to alleviate symptoms (78.6%). The participant’s
gastrointestinal symptoms were chronic in nature with the majority of the participants suffering
from gastrointestinal symptoms for greater than 10 years (33.7%) and very few participants
suffering from symptoms for less than 1 year (4.1%).
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Table 1
Pre-Intervention Demographic Characteristics of Participants
Variables

N

Age

97

Gender

98
89
9
98
15
76
5
2
0
97

Female
Male
Ethnicity
AfricanAmerican/Black/Caribbean
Caucasian
Hispanic
Native American
Asian
Weight
Log10 Transformation

(%)

Mean (SD)

Range

43.9 (11.15)

18-65

153.3 (0.84)
2.17 (0.098)

98-253

84.08 (13.4)

54-122

(90.8)
(9.2)
(15.3)
(77.6)
(5.1)
(2)
(0)

Waist Circumference

89

Attempted Treatments
None
1-2
3-5
>5

98
16
28
33
21

(16.3)
(28.6)
(33.7)
(21.4)

Duration of Symptoms
< 1 year
1-3 years
4-6 years
7-10 years
> 10 years

97
4
25
22
14
32

(4.1)
(25.5)
(22.4)
(14.3)
(32.7)

1.99-2.4

Note. Participant numbers may vary from 98 as not all participants answered all questions.

Description of Research Instruments (Pre-Intervention)
This section describes the study instruments, reliability in this sample, the mean scores,
standard deviations and the percentage of study participants above the normal range (Table 2).
Instruments used as a continuous variable were normally distributed except the original weight
variable.
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Table 2
Description of Research Instruments (Pre-Intervention)
Variable

M (SD)

Observed
Range

Possible
Range

Cut-off or
normative
value

Cronbach
Alpha
(without
means)

Weight
Weight Log10
Waist
Circumference

153.3 (36.71)
2.17 (0.098)
84.08 (13.44)

98-253
1.99-2.4
54-122

N/A
N/A
N/A

Perceived
Stress Scale
(PSS-10)

16.6 (5.43)

2-29

0-40

Normative
for female
(13.7) and
males (12.1)
68.3%
scored
above 13
Normative
value 125.8
99%
scored
below 124

0.876

Gastrointestinal
Quality of Life
Index (GQOLI)
Total

95.4 (15.73)

57-131

0-144

GQOLI Social
GQOLI
Emotional

12.28 (5.47)
12.63 (3.68)

5-16
3-20

0-16
0-20

0.646
0.823

GQOLI
Physical

14.43 (5.47)

1-26

0-28

0.793

GQOLI
Symptoms

53.34 (7.10)

33-68

0-76

0.668

0.870

Waist Circumference. Waist circumference was measured in centimeters. Participants
were advised to measure their waist circumference at the same time of day. Waist circumference
was measured parallel to the floor and in line with the umbilicus. Participants were instructed to
measure waist circumference flush against bare skin. Waist circumference measurements ranged
from 54-122 centimeters.
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Weight. Weight was measured in pounds with results ranging from 98-253 pounds.
Participants were advised to measure on the same scale, at the same time of day, and in the same
(or no) clothes to maintain internal consistency. Although only waist circumference was reported
in the clinical research questions, the tests were run to examine weight and waist circumference
to evaluate significance. Analyses were run using both the weight before transformation and after
the log transformation to determine if there were any differences, none were noted.
Perceived Stress Scale. Participants suffering from Functional Gastrointestinal Disorders
were evaluated for their perceived level of stress using the 10-item, Likert-type Perceived Stress
Scale (Cohen & Williamson, 1988). Scores ranged from 2-29 with higher scores indicating
higher levels of stress. The normative scores for females was 13.7 and for males was 12.1
(Cohen & Williamson, 1988). In this sample, 68.3% of the participants’ scored above 13 on the
Perceived Stress Scale. Out of the nine males in this sample, 5 scored above 12.5 on the
Perceived Stress Scale (55.6%). Out of the eighty-five females in this sample, 64 scored above
14 on the Perceived Stress Scale (75.3%). Cronbach’s alpha for the sample was an acceptable
0.88 (Di Lorio, 2005).
Gastrointestinal Quality of Life Index. Participants suffering from Functional
Gastrointestinal Disorders were evaluated for their gastrointestinal quality of life based on the
Gastrointestinal Quality of Life Index (Eypasch, 1995). Scores ranged from 57-131 with lower
scores associated with lower quality of life. The normative value for the Gastrointestinal Quality
of Life index is 125.8 (Eypasch, 1995). In this sample, at baseline, 99% of the participants scored
below 124 with only one participant scoring 131. Several other studies evaluating participants
with gastrointestinal dysfunction had similar results where the study participants had
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significantly lower levels of gastrointestinal quality of life than the normative levels in the
healthy population (Damon et al., 2008; Shi et al., 2011; Wierdsma et al., 2009).
The Gastrointestinal Quality of Life Index was divided into four subcategories including
emotional, physical, social, and symptoms. Cronbach’s alpha for each subcategory and total from
the sample is as follows: emotional (0.82), physical (0.79), social (0.65), symptoms (0.67), and
total (0.87). For the purpose of this study, subcategories were not tested separately due to low
reliability based on their Cronbach’s alpha scores (Di Lorio, 2005). The total Gastrointestinal
Quality of Life Index score was normally distributed based on Fisher’s exact skewness statistic
(1.2) and kurtosis (0.85) (Munro, 2005). The total Gastrointestinal Quality of Life Index score
had an acceptable Cronbach’s alpha of 0.87 (Di Lorio, 2005).
Pre-Intervention Clinical Research Questions
The following research questions were conducted using the pre-intervention data
findings.
Results for Research Question 1
Research Question 1: What demographic factors (age, gender, ethnicity, duration of
symptoms, and number of attempted treatments) are associated with a lower level of
gastrointestinal quality of life using the Gastrointestinal Quality of Life Index?
Age. Correlational analysis was used to evaluate whether age was associated with a lower
level of gastrointestinal quality of life. Data indicated that there was no statistically significant
association between age and gastrointestinal quality of life scores (r = .022, p = .83). For the
purpose of this study, all of the independent variables were included in the Pearson correlation as
seen in Table 3.
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Gender. An independent samples t-test was used to evaluate whether gender was
associated with a lower level of gastrointestinal quality of life. The covariate, gender, was
dichotomously coded 0/1 for “male” or “female”. The research found no statistically significant
association between gastrointestinal quality of life scores between females (M = 94.64, SD =
15.76) and males (M = 102.85, SD = 14.15); t (96) = 1.5, p = .14).
Ethnicity. An independent samples t-test was used to test the association between
ethnicity and gastrointestinal quality of life. The covariate, ethnicity, was dichotomously coded
0/1 for “Caucasian” or “Minority”. There was statistically significant association between
gastrointestinal quality of life and ethnicity. Minorities (M = 88.37, SD = 14.22) reported
significantly lower gastrointestinal quality of life than Caucasians (M = 97.43, SD = 15.64); t
(96) = -2.44, p = .02).
Duration of Symptoms. An independent samples t-test was conducted to examine the
association between duration of symptoms and lower gastrointestinal quality of life. The
covariate, duration of symptoms, was dichotomously coded 0/1 for “less than 3 years” or
“greater than 3 years”. There was no statistically significant association between less than 3
years of symptoms (M = 94.86, SD = 18.06) and greater than 3 years of symptoms (M = 95.34,
SD = 14.7; t (95) = -.137, p = .89).
The analysis was verified with the initial data grouping for duration of symptoms (less
than 1 year, 1-3 years, 4-6 years, 7-10 years, and greater than 10 years) with one-way ANOVA
testing. No statistically significant differences were seen F (4, 92) = 2.06, p = .093.
Number of Attempted Treatments. An independent samples t-test was conducted to
examine the association between the number of attempted treatments and lower gastrointestinal
quality of life. The covariate, number of attempted treatments, was dichotomously coded 0/1 for
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“less than 3 treatments” or “greater than 3 treatments”. There was a statistically significant
association between less than 3 attempted treatments (M = 100.33, SD = 15.57) and greater than
3 attempted treatments (M = 91.37, SD = 14.79; t (96) = -2.91, p < .01) on gastrointestinal
quality of life. Therefore, the participants that had attempted more than 3 different treatments had
significantly lower gastrointestinal quality of life.
The analysis was verified with the initial data grouping for the number of attempted
treatments (no treatment, 1-2 different treatments, 3-5 different treatments, and greater than 5
treatments) with one-way ANOVA testing. The overall F for the one-way ANOVA was
statistically significant F (3, 94) = 2.82, p = .043. Post hoc testing was conducted using Tukey’s
HSD tests with no statistically significant difference between groups (p = .11).
Results for Research Question 2:
Research Question 2: What is the association between participants’ perceived stress and
gastrointestinal quality of life?
Since there were similarities between these two instruments, correlations between the
questions on the instruments were evaluated. Although there were several significant
correlations, there were only two items that were moderately correlated (r < -.585). Correlational
analysis was used to evaluate the association between participants’ perceived stress and
gastrointestinal quality of life. Initial data screening indicated that both variables were normally
distributed. There was a low negative correlation between the overall scores on the perceived
stress and gastrointestinal quality of life scores (r = -.326, p = .001). Therefore, the more
perceived stress participants reported the lower their gastrointestinal quality of life. Table 3
reports the Pearson correlations between all the main variables in this study.
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Table 3
Pearson Correlations between the Major Variables (Pre-Intervention)
2

1. Age

1
-

2. Gender

.170

-

3. Ethnicity

-.161

.086

-

4. Duration of
Symptoms

.086

.024

-.077

-

5. Attempted
Treatments

.141

.210*

-.006

.143

-

6. Weight
(Log)

.083

-.369**

.094

.003

-.111

-

7. Waist
Circumference

.218*

-.244

.078

.096

-.028

.761**

-

8. Perceive
Stress Scale

.035

.166

.097

.016

.163

.100

-.024

-

.241*

.014

-.285** -.164

-.212*

-.326**

9.
.022
-.152
Gastrointestinal
Quality of Life
Note: * p < .05, ** p < .01

3

4

5

6

7

8

9

-

Results for Research Question 3:
Research Question 3: Controlling for demographic variables (age, gender, ethnicity,
duration of symptoms, and number of attempted treatments) what is the association of perceived
stress on gastrointestinal quality of life?
Prior to beginning the analysis, the independent variables (age, gender, ethnicity, duration
of symptoms, number of attempted treatments, and perceived stress) were examined for
multicollinearity. There was only one statistically significant correlation between the
independent variables including gender and number of attempted treatments (r = .21, p = .04).
This was a weak correlation indicating multicollinearity was not a problem (Munro, 2005).
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A simultaneous multiple linear regression was conducted to control for each variables
effect on each other and to test the relationship between age, gender, ethnicity, duration of
symptoms, number of attempted treatments, perceived stress, and gastrointestinal quality of life.
Regression results indicated that the model accounted for 22.1% of the variance in the perceived
stress and gastrointestinal quality of life (R2= .221, R2adj= .168, F (6, 89)= 4.206, p < .01). Table
4 summarizes the multiple regression analysis.
The results of this simultaneous regression report there are three statistically significant
predictors of gastrointestinal quality of life including: ethnicity, perceived stress, and attempted
treatments. Minorities, higher levels of perceived stress, and greater than 3 attempted treatments
were associated with lower gastrointestinal quality of life after controlling for the other
independent variables. Therefore, gastrointestinal quality of life is negatively correlated with
perceived stress; as the participants reported higher levels of perceived stress their
gastrointestinal quality of life decreased.
Table 4
Results of Simultaneous Regression of Predictors of Gastrointestinal Quality of Life Scores

Variable

b weights

Constant
119.97
Age
.095
Gender
-2.893
Ethnicity
-7.303
Perceived Stress
-.845
Attempted Treatments
-6.901
Duration of Symptoms 1.267
Note: * p < .05, ** p < .01

Std. β weights

.066
-0.54
-.196
-.288
-.219
.037

t

p value

12.16
.673
-.545
-2.03
-2.98
-2.23
.391

.00
.503
.587
.045*
.004**
.028*
.697
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Results for Research Question 4:
Research Question 4: What demographic factors (age, gender, ethnicity, duration of
symptoms and number of attempted treatments) are associated with an increased waist
circumference?
Age and waist circumference was normally distributed and interval/ratio level data
therefore the association between age and waist circumference was tested with Pearson’s
correlation coefficient. An independent samples t-test was conducted to test the association
between gender, ethnicity, duration of symptoms, and number of attempted treatments on waist
circumference. The only statistically significant association was between gender and waist
circumference with males having a larger waist circumference than females. See table 5 for a
summary of the independent samples t-test and Pearson correlation for the analysis.
Table 5
Examining Association of Age, Gender, Ethnicity, Duration of Symptoms, and Number of
Attempted Treatments on Waist Circumference
Variable

M (SD)

Age

43.90 (11.15)

t

r

P value

.22

.42

Gender
Male
Females
Ethnicity
Caucasians
Minorities
Duration of Symptoms
Less than 3 years
Greater than 3 years
Number of Attempted Treatments
Less than 3
More than 3
Note: *p < .05

93.82 (11.71)
82.99 (13.24)

2.35

.021*

83.50 (13.49)
85.95 (13.43)

.73

.468

82.18 (13.18)
85.02 (13.59)

-.89

.380

84.48 (14.6)
83.73 (12.47)

.26

.795
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Results for Research Question 5:
Research Question 5: Controlling for demographic variables (age, gender, ethnicity, duration
of symptoms, and number of attempted treatments), what is the association between perceived
stress and waist circumference and weight?
In this study, there was no statistically significant association between perceived stress and
waist circumference (r = -.024, p = .822), therefore a simultaneous multiple linear regression
controlling for the independent variables was not conducted.
Results for Research Question 6:
Research Question 6: Controlling for demographic variables (age, gender, ethnicity, duration
of symptoms, and number of attempted treatments), is there an association between
gastrointestinal quality of life and waist circumference?
Prior to beginning the analysis, the independent variables (age, gender, ethnicity, duration of
symptoms, number of attempted treatments, and gastrointestinal quality of life) were examined
for multicollinearity. Although there were three statistically significant correlations, the strengths
of the correlations remained low (r < -.285, p < .01). This is a low relation indicating
multicollinearity was not a problem (Munro, 2005).
A simultaneous multiple linear regression was conducted to test the relationship between age,
gender, ethnicity, duration of symptoms, number of attempted treatments, and gastrointestinal
quality of life on waist circumference. Regression results indicated that the model accounted for
21.2% of the variance in the participants’ gastrointestinal quality of life and waist circumference
(R2= .212, R2adj= .153, F (6, 80)= 3.59, p < .01). There were three statistically significant
predictors of waist circumference including age, gender, and gastrointestinal quality of life after
controlling for independent variables. Waist circumference was positively correlated with age; as

RESTORING DIGESTIVE HEALTH

75

age increased, waist circumference increased. There was a statistically significant association
between the male participants in this sample and an increased waist circumference. Waist
circumference was negatively correlated with gastrointestinal quality of life; the larger the
participants’ waist circumference the lower their gastrointestinal quality of life.
Table 6
Results of Simultaneous Regression of Predictors for Waist Circumference

Variable

b weights

Std b weights

t

p value

(Constant)
Age
Gender
Ethnicity
Gastrointestinal
Quality of Life
Attempted Treatments
Duration of Symptoms

102.164
.349
-14.421
2.850
-.234

.289
-.328
.091
-.274

7.848
2.800
-3.151
.876
-2.566

.000
.006**
.002**
.383
.012*

-2.002
2.771

-.075
.094

-.701
.927

.485
.357

Note: * p < .05, ** p < .01
Post-Intervention Data
Sample Characteristics
Out of the 98 participants that enrolled in the study, 86 participants completed the entire
8-week study. Demographics of the 86 participants that completed the entire 8-week intervention
can be found in Table 7.
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Table 7
Post-Intervention Demographic Characteristics of Participants
Variables

N

Age

85

Gender

86

(%)

Range

44.34 (11.08) 18-65

Female

77

(89.5)

Male

9

(10.5)

Ethnicity

Mean (SD)

86

AfricanAmerican/Black/Carribbean 13

(12.1)

Caucasian

67

(62.6)

Hispanic

5

(4.7)

Native American

1

(0.9)

Asian

0

(0)

Weight

86

148.97 (34.3) 98-250

Log10 Transformation

86

2.16 (0.093)

1.99-2.4

Waist Circumference

78

78 (12.74)

63-121

Attempted Treatments

86

None

6

(7.0)

1-2

24

(27.9)

3-5

32

(37.2)

>5

24

(27.9)

Duration of Symptoms

86

< 1 year

4

(4.7)

1-3 years

19

(22.1)

4-6 years

24

(27.9)

7-10 years

10

(11.6)

> 10 years

29

(33.7)

Note. Participant numbers may vary from 86 as not all participants answered all questions.

Two participants completed the pre-intervention survey, but withdrew prior to week
one’s survey. One of the participants was a 39-year-old Caucasian female with the initial
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complaint of diarrhea, reflux, and abdominal pain with and without food; this participant
withdrew due to family illness. The other participant was a 39-year-old Caucasian female with
initial complaints of constipation, bloating, and flatulence. The researcher reached out to this
participant numerous times without a response; therefore the reason for withdrawal remains
unknown.
One participant withdrew by week 3. This participant was a 38-year-old Caucasian
female with initial complaints of constipation, bloating, and flatulence. She withdrew due to
unexpected travel out of the country without Internet excess.
Three participants withdrew by week 4 of the intervention: (1) 33-year-old Caucasian
female with initial complaints of bloating, reflux, flatulence, and abdominal pain with food, (2)
38-year-old Caucasian female with initial complaints constipation, bloating, and belching, and
(3) 59-year-old Caucasian female with initial complaints of constipation and bloating. The first
participant withdrew due to increased bloating, the second withdrew due to increased
constipation, and the third participant withdrew for unknown reasons.
One participant withdrew by week five. This participant was a 35-year-old African
American female with initial complaints of constipation, bloating, and reflux. The researcher
reached out to her numerous times without a response.
One participant withdrew by week six. This participant was a 42-year-old Caucasian
female with complaints of constipation, bloating, reflux, and flatulence. This participant reported
being too busy with her kids’ schedules.
Two participants withdrew by week seven. One participant was a 55-year-old Caucasian
female with initial complaints of constipation, bloating, and flatulence. The other participant was
a 23-year-old Native American female with initial complaints of diarrhea, bloating, reflux,
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flatulence, and abdominal pain with food. The researcher reached out to both of these
participants numerous times without a response.
Lastly, two participants did not complete the post-intervention survey. One of the
participants was a 57-year-old African American female with initial complaints of constipation,
bloating, reflux, flatulence, and abdominal pain with food. The other participant was a 31-yearold Caucasian female with initial complaints of diarrhea, constipation, bloating, reflux, and
abdominal pain with food. The researcher reached out to both of these participants without a
response.
Self-Reported Gastrointestinal Symptoms
Each participant was asked to report his or her gastrointestinal symptoms at baseline,
weekly, and after 8-weeks of probiotics, digestive enzymes, and glutamine. Each participant was
asked to check which gastrointestinal symptom they experienced in the previous week. The
covariate, gastrointestinal symptoms, was dichotomously coded 0/1 for “no” or “yes”. In order to
do a more thorough comparison of symptoms, only those participants that completed the entire
8-week study were included (n = 86). A paired samples t-test was conducted to evaluate whether
there was statistically significant improvement in self-reported gastrointestinal symptoms after
the 8-week intervention. The researcher verified the results with McNemar's test and found the
same results. The only significant reduction in symptoms was abdominal pain related to food.
The pre and post intervention results are shown in Table 8.
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Table 8
Self-Reported Gastrointestinal Symptoms of Sample Completing Entire 8-Week Study
Pre-Intervention
N=86

Post-Intervention
N= 86

Symptoms

N

(%)

N

(%)

t

p value

Diarrhea

28

(32.6)

26

(30.2)

.705

.483

Constipation

49

(57.0)

48

(55.8)

.332

.741

Bloating

77

(89.5)

74

(86.0)

1.000

.320

Reflux

27

(31.4)

30

(34.9)

-9.04

.369

Belching

22

(25.6)

18

(20.9)

1.070

.288

Excessive flatulence

53

(61.6)

45

(52.3)

1.583

.117

Abdominal pain
related to food
Abdominal pain
unrelated to food
Note: ** p < .01

46

(53.5)

34

(39.5)

2.787

.007**

16

(18.6)

15

(17.4)

.257

.798

Post-Intervention Description of Research Instruments
Prior to discussing the post-intervention research questions, table 9 provides a description
of the research instruments and findings after eight weeks of probiotics digestive enzymes and
glutamine.
Table 9
Description of Research Instruments (Post-Intervention)
Variable

M (SD)

Observed
Range

Possible
Range

Weight
Weight Log10
Waist
Circumference

148.97 (34.33)
2.16 (0.093)
84.43 (12.74)

98-250
1.99-2.4
63-121

N/A
N/A
N/A

Perceived

15.78 (5.89)

3-28

0-40

Cut-off or
normative
value

Cronbach
Alpha
(without
means)

Normative

0.889
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Stress Scale
(PSS-10)

for female
(13.7) and
males (12.1)
72.1%
scored
above 13
Normative
value 125.8
81.4%
scored
below 124

Gastrointestinal
Quality of Life
Index (GQOLI)
Total

105.63 (18.43)

59-138

0-144

0.921

GQOLI Social
GQOLI
Emotional

12.84 (2.80)
13.99 (3.88)

6-16
3-20

0-16
0-20

0.691
0.866

GQOLI
Physical

17.13 (5.49)

4-28

0-28

0.800

GQOLI
Symptoms

58.58 (8.73)

38-74

0-76

0.827

Perceived Stress Scale. The Perceived Stress Scale was normally distributed in the post
intervention data based on Fisher’s exact skewness statistic (.31) and kurtosis (.78) (Munro,
2005). The normative scores for females was 13.7 and for males was 12.1 (Cohen & Williamson,
1988). In this sample, 72.1% of the participants’ scored above 13 on the Perceived Stress
Scale. Out of the nine males in this sample, 3 scored above 12.5 on the Perceived Stress Scale
(33.3%). Out of the seventy-three women that completed all of the necessary questions, 55
scored above 14 on the Perceived Stress Scale (75.3%). The Perceived Stress Scale had an
acceptable Cronbach’s alpha of .89 (Di Lorio, 2005).
Gastrointestinal Quality of Life Index. The Gastrointestinal Quality of Life Index was
normally distributed in the post intervention data based on Fisher’s exact skewness statistic
(1.94) and kurtosis (.65) (Munro, 2005). The normative value for the Gastrointestinal Quality of
Life index is 125.8 (Eypasch, 1995). In this sample (n = 86), 70 (81.4%) of the participants
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scored 124 or lower on the total Gastrointestinal Quality of Life Index. The total Gastrointestinal
Quality of Life Index had an acceptable Cronbach’s alpha of .92 (Di Lorio, 2005).
Weight and Waist Circumference. Weight was not normally distributed in the postintervention data based on Fisher’s exact skewness statistic (4.04) and kurtosis (.86) (Munro,
2005; Tabachnick & Fidell, 2006). Analysis of the data indicated that there were no significant
outliers. After completing a logarithm transformation, weight was normally distributed based on
Fisher’s exact skewness statistic (2.58) and (.78). The resulting mean was 2.16 (SD = 0.94).
Similarly to the pre-intervention data, there was a strong correlation between weight and
waist circumference (r = .812, p < .01). Waist circumference was normally distributed in the
post-intervention data based on Fisher’s exact skewness (2.76) and kurtosis (.32) (Munro, 2005).
Due to the strong correlation and normality of data, only the participants’ waist circumference
was reported when answering the clinical questions.
Post-Intervention Clinical Research Questions
The following research questions were conducted using the post-intervention data.
Results for Research Question 7:
Research Question 7: After 8-week treatment with probiotics, digestive enzymes, and
glutamine, is there an association between perceived stress and gastrointestinal quality of life,
weight, and waist circumference?
Correlational analysis was used to evaluate the association between participants’
perceived stress, gastrointestinal quality of life, weight, and waist circumference after 8-week
treatment with probiotics, digestive enzymes, and glutamine. Table 10 reports the Pearson
correlations between all the main variables in this study after the 8-week intervention.
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Table 10
Pearson Correlations between the Major Variables (Post-Intervention)
2

1. Age

1
-

2. Gender

-.110

-

3. Ethnicity

.167

.090

-

4. Duration of
Symptoms

.025

.051

-.185

-

5. Attempted
Treatments

.041

.308**

.037

.274*

-

6. Weight
(Log)

.131

-.330**

.025

-.075

.021

-

7. Waist
Circumference

.080

-.280*

.043

-.141

.000

.812**

-

8. Perceive
Stress Scale

.040

.123

.076

-.021

.386**

.115

.057

-.166

.108

-.382** -.012

9.
-.030
-.208
Gastrointestinal
Quality of Life
Note: * p < .05, ** p < .01

3

4

5

6

7

8

9

-

-.050 -.526*

-

Perceived Stress Scale. The association between perceived stress and gastrointestinal
quality of life, weight, and waist circumference was tested with Pearson’s correlation coefficient.
There was no statistically significant association between perceived stress and waist
circumference (r = .057, p = .619). There was a statistically significant moderate correlation
between perceived stress and gastrointestinal quality of life (r = -.526, p < .01). Participants with
higher perceived stress reported the lower gastrointestinal quality of life.
Gastrointestinal Quality of Life. The association between gastrointestinal quality of life
and perceived stress, weight, and waist circumference was tested with Pearson’s correlation
coefficient. There was no statistically significant association between gastrointestinal quality of
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life and waist circumference (r = -.05, p = .664). As previously stated, there was a statistically
significant moderate correlation between gastrointestinal quality of life and perceived stress (r =
-.526, p < .01). Therefore the higher perceived stress reported the lower gastrointestinal quality
of life.
Waist Circumference. The association between waist circumference, perceived stress,
and gastrointestinal quality of life was tested with Pearson’s correlation coefficient. There was
no statistically significant association between waist circumference and gastrointestinal quality
of life (r = -.05, p = .66) or perceived stress (r = .057, p = .62) in the post-intervention data.
Results for Research Question 8:
Research Question 8: Controlling for demographic variables (age, gender, ethnicity,
duration of symptoms, and number of attempted treatments) after 8-week treatment with
probiotics, digestive enzymes, and glutamine what is the association of perceived stress on
gastrointestinal quality of life?
Prior to beginning the analysis, the independent variables (age, gender, ethnicity, duration of
symptoms, number of attempted treatments, and perceived stress) were examined for
multicollinearity. Although there were three statistically significant correlations, the strengths of
the correlations remained low (r = 3.86, p < .01) indicating multicollinearity was not a problem
(Munro, 2005).
A simultaneous multiple linear regression was conducted to test the relationship between age,
gender, ethnicity, duration of symptoms, number of attempted treatments, and perceived stress
on gastrointestinal quality of life. Regression results indicated that the model accounted for 35%
of the variance in the participants’ perceived stress and gastrointestinal quality of life (R2= .350,
R2adj= .300, F (6, 78)= 7.005, p < .01). There were two statistically significant predictors of
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gastrointestinal quality of life after controlling for independent variables included the number of
attempted treatments and perceived stress. The higher level of perceived stress and the more
treatments a participant had tried the lower the participants’ gastrointestinal quality of life. Table
11 summarizes the multiple regression analysis.
Table 11
Results of Simultaneous Regression of Predictors of Gastrointestinal Quality of Life

Variable

b weights

(Constant)
137.834
Age
-.124
Gender
-4.376
Ethnicity
-4.214
Duration of Symptoms 7.184
Attempted Treatments -9.144
Perceived Stress
-1.221
Note: * p < .05, ** p < .01

Std b weights

t

p value

-.075
-.074
-.096
.172
-.238
-.383

13.180
-.770
-.750
-1.019
1.727
-2.212
-3.769

.000
.443
.456
.311
.088
.030*
.000**

Results for Research Question 9:
Research Question 9: Controlling for demographic variables (age, gender, ethnicity,
duration of symptoms, and number of attempted treatments) after 8-week treatment with
probiotics, digestive enzymes, and glutamine, what is the association between perceived stress
on waist circumference?
In this study, there was no statistically significant correlation between perceived stress
and waist circumference; therefore, a simultaneous multiple linear regression controlling for
independent variables was not conducted.
Results for Research Question 10
Controlling for demographic variables (age, gender, ethnicity, duration of symptoms, and
number of attempted treatments) after 8-week treatment with probiotics, digestive enzymes, and
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glutamine, what is the association between gastrointestinal quality of life on waist
circumference?
In the study, there was no statistically significant correlation between gastrointestinal
quality of life and waist circumference; therefore, a simultaneous multiple linear regression
controlling for variables was not conducted.
Results for Research Question 11
Research Question 11: After 8-week treatment with probiotics, digestive enzymes, and
glutamine, is there a statistically significant change in the gastrointestinal quality of life, weight,
waist circumference, and perceived stress?
Paired samples t-test was used to evaluate whether there was statistically significant
change in gastrointestinal quality of life, weight, waist circumference, and perceived stress after
8 weeks of probiotics, digestive enzymes, and glutamine. A summary of the findings can be
found in Table 12.
Table 12
Paired Samples T-Test after 8-Week Intervention
Pre-Intervention

Post-intervention

N= 86
M (SD)

N= 86
M (SD)

t

p value

Gastrointestinal
Quality of Life

95.95 (15.94)

105.63 (18.43)

-6.55

.000**

Weight Log

2.17 (.097)

2.16 (.094)

2.55

.012*

Waist
Circumference

84.21 (13.11)

84.18 (12.8)

.039

.969

15.78 (5.89)

1.302

.196

Variable

Perceived Stress
16.37 (5.38)
Note: * p < .05, ** p < .01
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Gastrointestinal Quality of Life. There was a significant difference in the gastrointestinal
quality of life scores from the pre-intervention scores (M = 95.95, SD = 15.94) to postintervention scores (M = 105.63, SD = 18.43); t (85)= -6.56, p < .01. Therefore, participants had
statistically significant improvements in their gastrointestinal quality of life after 8 weeks of
probiotics, digestive enzymes, and glutamine.
Weight. There was a significant difference in the participants’ weight from pre-intervention
(M = 2.17, SD = .097) to post-intervention (M = 2.16, SD = .094); t (84) = 2.55, p = .012.
Initially weight was not normally distributed; therefore the original weight data was examined
with a Wilcoxon signed-rank test to verify the significance. A Wilcoxon signed-rank test showed
that after 8 weeks of probiotics, digestive enzymes, and glutamine there was a statistically
significant weight lost in participants (Z = -4.71, p < .01). The pre-intervention weight mean was
152.18 pounds and the post-intervention weight was 149.07. As evident, with both the paired
samples t-test and Wilcoxon signed-rank test, participants lost a statistically significant amount
of weight over the 8-week intervention.
Waist Circumference. There was no significant difference in waist circumference prior to
the study (M = 84.21, SD = 13.11) and after the 8-week study (M = 84.18, SD = 12.8); t (70) =
.39, p = .969.
Perceived Stress. There was no significant change in perceived stress from baseline (M =
16.37, SD = 5.38) to after the 8-week study (M =15.78, SD = 5.89); t (85) = 1.302, p = .196.
Conclusion
This chapter presented the results of the research study. A total of 98 adults suffering
from Functional Gastrointestinal Disorders were recruited from an Integrative Medicine office in
Atlanta, Georgia. A total of 86 participants completed the entire 8-week intervention of
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probiotics, digestive enzymes, and glutamine. Results indicated that there was a statistically
significant association between minorities, higher levels of stress, and greater than 3 attempted
treatments with lower gastrointestinal quality of life based on the Gastrointestinal Quality of Life
Index.
There was no statistically significant association between age, gender, or duration of
symptoms and gastrointestinal quality of life. Men and increasing age were associated with
larger waist circumferences. Results indicated that even though all of the self-reported
gastrointestinal symptoms improved over the 8-week intervention (except for reflux), the only
statistically significant improvement was seen in abdominal pain related to food.
After the 8-week intervention, there was significant weight loss and increased
gastrointestinal quality of life scores based on the Gastrointestinal Quality of Life Index. In
conclusion, the results of this study support the use of probiotics, digestive enzymes, and
glutamine to improve weight loss and gastrointestinal quality of life in individuals suffering from
Functional Gastrointestinal Disorders.
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CHAPTER V
Discussion

The purpose of this 8-week prospective cohort study was to determine whether
probiotics, digestive enzymes, and glutamine are an effective regimen for improving
gastrointestinal symptoms. Chapter V presents a discussion of the study’s results and concludes
with the study’s strengths, limitations, implications for practice, and future research. This study
is unique as it is the first to examine the combined benefits of probiotics, digestive enzymes, and
glutamine for the management of Functional Gastrointestinal Disorder symptoms.
This gastrointestinal protocol was designed to be an alternative method for restoring
digestive health rather than managing symptoms in individuals suffering from Functional
Gastrointestinal Disorders. The findings of this study examine the demographics associated with
Functional Gastrointestinal Disorders and explore the hypothesis that there is a brain-gut
connection. This study examined the brain-gut connection through the evaluation of the
participants’ perceived stress based on the Perceived Stress Scale and gastrointestinal quality of
life based on the Gastrointestinal Quality of Life Index.
Demographics
Age
When examining the impact of age on Functional Gastrointestinal Disorders it does not
appear to be an important demographic variable. In this study, there was no significant
correlation between age and perceived stress or gastrointestinal quality of life. The only
significant finding related to the participants’ age was that as their age increased, their waist
circumference increased as well. Previous studies have found similar results. A longitudinal
study conducted over 15 years in Australia found age to be the most important factor associated
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with change in both weight and waist circumference (Arabshahi, Lahmann, Williams & van der
Pols, 2014). Participants in this study continued to gain weight and waist circumference until age
55 and 65 years old, respectively (Arabshahi et al., 2014).
The age most affected by Functional Gastrointestinal Disorders remains inconclusive.
This research study limited its sample to participants between the ages of 18-65 years old. The
findings in this study resulted in a wide range of ages from 18-65 years old with a mean age of
43.9 years old. The results of this study are congruent with other study findings. One study found
that individuals younger than 50 years old were affected by irritable bowel syndrome more
frequently (Scalera & Loguercio, 2012). Another large cohort study of 4,224 patients with
Functional Gastrointestinal Disorders found the mean age to be 47.6 years old with an age range
from 16-93 years old (Ford et al., 2014). This is similar to a large case-control study of 23,471
diagnosed with Functional Gastrointestinal Disorders that reported a mean of 51.4 years old
(Ford, Talley, et al., 2014). In Europe, a study was conducted that examined 199 patients with
Functional Gastrointestinal Disorders and found the mean age to be 50 years old, with the ages
ranging from 21-85 years old (Lahner et al., 2013).
Although this study’s mean age results were similar to those found in other larger studies,
it is important to remember that Functional Gastrointestinal Disorders do not discriminate based
on age. Individuals can suffer from functional gastrointestinal symptoms from birth until death.
This study limited the inclusion criteria to adult participants; however Functional
Gastrointestinal Disorders affect children as well. Roughly 38% of school aged children
complain of abdominal pain from functional origin on a weekly basis (Saps, Seshadri,
Sztainberg, Schaffer, Marshall, & Lorenzo, 2009). It is estimated that anywhere from 25-66% of
children with Functional Gastrointestinal Disorders continue to experience gastrointestinal
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symptoms as adults (Campo et al., 2001). Therefore, patient outcomes can improve the earlier
healthcare providers initiate a plan of care focusing on restoring digestive health.
Gender
Atlanta Center for Holistic and Integrative Medicine has more female than male patients.
Since participants were recruited through the Center, it is not a surprise that the majority of the
participants in this study were female (90.8%). Due to the majority of the participants being
female, the analysis was run using females only to evaluate whether there were any differences
in their self-reported gastrointestinal symptoms pre- and post- intervention, none were noted.
However, literature worldwide has found that females suffer from Functional Gastrointestinal
Disorders more frequently than males (Markert et al., 2014; Scalera & Loguercio, 2012; Myer et
al., 2013; Sagawa et al., 2013; Ford et al., 2014; Porter et al., 2011; Lahner et al., 2013). In
Western countries, it is estimated that females suffer from irritable bowel syndrome three times
more frequently than males (Scalera & Loguercio, 2012). In Japan, a large Internet survey found
a higher prevalence of functional dyspepsia and irritable bowel syndrome in females than males
(Miwa, 2012). Porter et al (2011) found a seven-fold higher rate of functional constipation
among females compared to males.
In contrast, there was an epidemiological study conducted in Mexico that found all
Functional Gastrointestinal Disorders to be equally prevalent across both genders except for
irritable bowel syndrome and functional constipation, which was found to be more prevalent in
women (López-Colombo et al., 2012). The exact etiology behind female predominance remains
unclear. Further research is needed to explore the etiology behind this finding. Some possible
theories include hormonal changes (especially in menstruating women) and differences in
perceived stress since this study found a significant correlation between perceived stress and
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gastrointestinal quality of life. However, since there were so few males in this study further
research would need to be conducted to explore the impact gender has on Functional
Gastrointestinal Disorders.
Ethnicity
Research examining the association between ethnicities and Functional Gastrointestinal
Disorders remains limited. In this study sample, the majority of the participants were Caucasian
(77.9%). This finding is even more diverse than other research studies conducted in the past. One
study examined participants suffering from irritable bowel syndrome, diarrhea dominant (n =
380) and functional diarrhea (n = 95) (Ford et al., 2013). The study reported a sample that was
94.2% Caucasian in the irritable bowel syndrome group and 90.5% Caucasian in the functional
diarrhea group (Ford et al., 2013). Another study conducted by Ford et al. (2014) found the
majority of irritable bowel syndrome (87.4%) and chronic idiopathic constipation (88.9%)
patients to be Caucasian. In contrast, Myer et al. (2013) found no statistically significant
differences in ambulatory visits related to gastrointestinal symptoms between Caucasians and
African Americans (Myer et al., 2013).
Due to the majority of the participants being Caucasian, minorities were examined alone
for improvements in self-reported gastrointestinal symptoms pre- and post-intervention. There
were no statistically significant improvements in minorities’ self-reported gastrointestinal
symptoms pre- and post-intervention; however, there was a statistically significant improvement
in minorities gastrointestinal quality of life based on the gastrointestinal quality of life index.
While both Caucasians and minorities had statistically significant improvements in their
gastrointestinal quality of life, minorities had a larger change in their gastrointestinal quality of
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mean scores. Figure 2 presents the pre- and post- Gastrointestinal Quality of Life scores in
Caucasians versus minorities.
120

100

80
PreGQOLI

60

PostGQOLI
40

20

0
Minorities

Caucasians

Figure 2. Gastrointestinal Quality of Life Scores Pre- and Post- Intervention Based on Ethnicity
Even with the low minority representation, the results found in this study were
statistically significant. In this study, there was a significant association between minorities and
lower gastrointestinal quality of life based on the Gastrointestinal Quality of Life Index. Even
though there was an association between stress and gastrointestinal quality of life, the results of
this study found no significant association between minorities and higher levels of perceived
stress. Therefore, further research is needed to determine the reason why minorities have lower
gastrointestinal quality of life and the role ethnicity plays on Functional Gastrointestinal
Disorders.
Duration of Symptoms
The symptoms associated with Functional Gastrointestinal Disorders are typically
chronic in nature. The diagnosis of Functional Gastrointestinal Disorders is given after an
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individual has suffered from symptoms in the upper or lower gastrointestinal tract at least one
time per week for 6 months without an organic cause (Lahner et al., 2013).
In this study sample, the majority of the participants have suffered from functional
gastrointestinal symptoms for longer than 10 years (32.7%). This validates the notion that those
suffering from Functional Gastrointestinal Disorders have little to no improvement in their
symptoms, leading to physical, mental, and emotional distress. There were no statistically
significant differences found in the self-reported gastrointestinal symptoms pre- and postintervention between participants that had symptoms for less than three years and those that had
symptoms greater than three years. The purpose of this intervention is to offer an alternative
method to shorten the length of time individuals with Functional Gastrointestinal Disorders have
to suffer from the corresponding symptoms.
Number of Attempted Treatments
Due to the chronic nature of Functional Gastrointestinal Disorders, most individuals have
attempted a number of therapies to improve their symptoms without success. Individuals
suffering from functional gastrointestinal symptoms are desperate for relief. In this study, the
majority of participants had tried 3-5 different treatments (33.7%) to alleviate their symptoms. In
addition, the results of this study found a negative correlation between the number of attempted
treatments and gastrointestinal quality of life scores. In other words, the more treatments a
participant has tried the lower their gastrointestinal quality of life. There were no statistically
significant differences found in self-reported gastrointestinal symptoms pre- and postintervention between participants that had tried less than three different treatments and those that
had tried more than three different treatments.
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Conventional or standard treatment for functional gastrointestinal disorders focuses
primarily on symptom management with the use of laxatives, antidiarrheal, antispasmodics, or
antidepressants. This symptom management approach has not been effective for managing
Functional Gastrointestinal Disorders (Lahner et al., 2013). It is estimated that less than 50% of
patients with irritable bowel syndrome are satisfied with their treatment plan (Aucoin, 2014).
This is causing 21-51% of irritable bowel syndrome patients to seek complementary and
alternative modalities (Aucoin, 2014). This gastrointestinal protocol of probiotics, digestive
enzymes, and glutamine has the ability to restore digestive health and alleviate their symptoms.
Self-Reported Gastrointestinal Symptoms
Although the gastrointestinal symptoms improved (except for reflux) after the 8-week
intervention, the only statistically significant improvement was abdominal pain related to food.
There are several theories to support the improvement in abdominal pain related to food. For
instance, individuals that have a compromised digestive tract are more prone to having food
allergies and food sensitivities. Each of the three components in this gastrointestinal protocol
(probiotics, digestive enzymes, and glutamine) plays a unique role in enhancing digestion and
minimizing the negative effects of food allergies and sensitivities.
First of all, probiotics have been shown to function as a protective barrier, enhance
immune response, and clear pathogens in the gastrointestinal tract (Ritchie & Romanuk, 2012).
Marrs et al. (2013) conducted a systematic review to determine whether the human gut
microbiota plays a role in food allergies. Out of five studies evaluating the gut microbiota, three
of the publications reported significant findings to support the hypothesis that altered microbial
exposure modulates risk of food allergies (Marrs et al., 2013).
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Secondly, the amino acid glutamine is required for the normal production of
immunoglobulin A in the intestines (Resnick, 2010). Improving immunoglobulin A in the
mucosal lining can enhance the immune system and reduce the negative effects of food allergies
and sensitivities. Glutamine also has been shown to have anti-inflammatory benefits in the
intestinal tract (Ren et al., 2013). Therefore, glutamine can decrease the unpleasant side effects
associated with gut inflammation after being exposed to food allergies or food sensitivities.
Lastly, digestive enzymes have the ability to increase gastric digestion, which plays a role
on food allergies (Untersmayr, 2015). The specific digestive enzyme used in this research study,
Similase GFCF, contains enzymes that support the digestion of gluten and casein. These two
proteins have been shown to cause a number of side effects. Gluten has been shown to have
negative effects on individuals’ overall health including depression (Peters et al., 2014), foggy
mind, bloating, and abdominal pain (Di Sabatino, 2015). Haq et al. (2014) found casein to cause
a Th- mediated inflammatory response in the digestive tract of mice.
In conclusion, although this study did not examine the participants’ diet, the
implementation of this protocol can improve the way individuals respond to certain foods.
Further research would be needed to examine the impact of various diets on Functional
Gastrointestinal symptoms.
Additional Comments
Each week participants had the opportunity to leave additional comments. There were
several positive comments, as well as some negative feedback. It was interesting that some of the
participants reported symptoms returning after missing just one day of supplements. Table 13
presents some of the pertinent quotes found on the weekly survey.
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Table 13
Additional Comments Found on Weekly Survey
Week

Pros

Cons

Week 1

“Constipation not quite as bad”

“Feeling less bloaty. Still having some
days where I have excessive gross
gas...And dont feel fully ""regular""
yet...”

“My bloating has started to decrease some
and less nausea after my largest meal”
“Happy to say that my bowel movements
are very regular and good. Better than
normal. Also...been on vacation and
eating a lot. Desserts! So not expecting to
lose weight”

“Extreme amount of gas”
“Not noticing any changes yet. But
hopeful”
“Feel extra gassy”

“Symptoms less intense and frequent”
“My nausea does not seem to be as bad
after eating. Think the powder is part of
it.”
“I have noticed a difference with the
probiotic as I have less bloating and gas
than the previous week.”
“I will say that I have been going to the
bathroom more frequently and my stool is
softer, which I like.”

“I have more gas than usual. I feel like
I am having more normal stools. I have
begun an exercise program.”
“I was very bloated and constipated for
the first four days. It is better now but
not great.”
“I have experienced occasional nausea
while on the supplements.”
“Increased gas and stomach gurgling!”

“My bowel movements have become more
frequent.”
“I do feel like my constipation is a lot
better”

Week 2

“I feel I am having much less bloating, no
diarrhea, more steady consistent BM's”
“My digestive system seems to have
adjusted to the supplements!”
“Gas seems to be less and diarrhea was
only once”

“The excess gas is on a daily basis”
“Still experiencing slower transit of
bowels each day”

“Excited! The first time in 30 years I have “I believe my constipation has gotten
gone a week without taking laxatives of
worse since I started these supplements”
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some kind. I am 44 years old and had
constipation all my life. I am going regular “I did not feel as good this weak. But I
every morning!! That is a blessing!!”
have had a lot of excess stress.”
“Noticed I feel a burning in my adam
Apple area and stomach when I missed the
enzymes. I can see how how enzymes are
important.”
“less bloating!”

Week 3

“lol. It is my birthday week and I ate alot
but my waist is shrinking.”
“Feeling good!”
“Can see big difference in regularity. Less
run to restroom/ diarrhea”
“Feeling better mentally. Much less
bloating and cravings!”

“Experiencing extreme bloating when
coffee is consumed, which was not
present prior to this study. Significant
decrease in bowel movements as well.”

“Had a really bad flare up Sat through
Tues....very very gassy, bloated,
stomach pain, culminating in a lot of
diarrhea Monday night. Kept me up all
night.”
“Hormonal changes seems to change
how digestive system works!”

“Bowel movements are more regular”
“Reflux only 3 days last week. Getting
better.”

“These supplements make me so
constipated I am nauseous. I have to
stop taking them this week. I believe it is
the Glutamine, as I suspected I had
similar problems when I tried it in the
past.”
“Still no significant changes in bowels,
gas, belching...still hopeful though!”
“I have not had bad stomach pains until
this week. I ate some ice cream and it
killed my stomach.”

Week 4

“Bloating still present, but feels reduced.”

“Excessive gas this week. Constipation
is little better from last week”
“I've occasionally felt nauseated after
taking the digestive enzymes.”

“Starting to notice that my bowel
movements are more complete, and I don't
still feel constipated afterwards.”

Week 5

“I have felt really good this week. I have
had zero gluten or dairy.”
“This program has consistently improved
constipation symptoms.”

“Really lots of gas”
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“The constipation was only for two days
this week and no discomfort. Much better
than prior weeks. I do see improvement”

Week 6

“Bloating discomfort is less!”
“Overall, my stomach has felt really good
doing this study. I still have a little
constipation.”
“Feeling better, but still occasionally a lot
of gas”
“See improvement in consistent bowel
movements--even eating red meat and
some dairy. No problems. I'm in week 2
of a workout regimen so expect to see
weight and inches lost due to this”

98
“I've noticed bloating and gurgling for a
couple hours after the enzymes are
taken.”

“By week 6 I discovered that the
supplements were making more
uncomfortable than comfortable. My
constipation did not subside but I also
become more crampy and bloated when
taking the supplements.”
“Enjoying the process, yet still no
significant changes in belching and
constipation. Thank you for doing this
research though.”
“I am extremely constipated.”

“While doing this study I have only had
one really bad stomach pains. Usually I
would have had several.”

Week 7

“Really want to purchase these items after
the test is over if possible. Thanks”
“Gas symptoms are consistent but the
“I'm surprised that I've struggled with
supplements aid in digestion (constipation constipation throughout this study.”
has improved dramatically). This is a more
“These past 2 weeks I have been extremely
comfortable remedy than laxatives.”
“Bloating sensation is not as
uncomfortable”
“I think the results would be more
effective if I took the supplements for a
longer period of time. I can feel the
benefits, but I don’t think 8 weeks is
enough time.”
“I experienced the above symptoms only
on the 1 day that I missed my supplements
for the day. Otherwise, I have been 95%
symptom free, and have recommended the
supplements to many people with similar

constipated, gassy and belching. I haven't
felt good at all.”
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symptoms.”
“Feeling more joyful & energetic, Praise
the Lord!!”
“Noticed a difference when I missed the
glutamine.”
“Bloating was better this week”
“My stomach feels great! Still some
constipation but overall I feel good.”
“Bloating was significantly less this week
- not sure why”
“the day I skipped I had the issues”
“Thanks for the trial made a big difference
in my life.”
“This is the first week I've not had diarrhea
- so happy!”

Instruments
Weight and Waist Circumference
The results of this study reported a mean waist circumference of 84 cm. The mean waist
circumference in this study (84 cm) is below the criteria for the diagnosis of overweight or
obesity (> 88 cm) based on the National Institute of Health (n.d) criteria. Due to the fact that
participants did not report height, the researcher was unable to calculate participants body mass
index to classify whether the participants were overweight or obese. However, based on waist
circumference alone, the results of this study vary from the majority of the studies found in
literature examining the relationship between Functional Gastrointestinal Disorders and weight
and waist circumference.
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Several studies found that individuals suffering from Functional Gastrointestinal
Disorders were more likely to be overweight or obese (Lee et al., 2015, Yilmaz, 2013; Lahner et
al., 2013). Lee et al (2005) reported an increased waist circumference associated with an
increased risk of irritable bowel syndrome. Yilmaz (2013) conducted a descriptive study in
Turkey to evaluate effects of obesity on gastrointestinal quality of life. The results of this study
found that obese patients suffered from gastrointestinal symptoms more frequently and had a
decreased quality of life based on the Gastrointestinal Quality of Life Index (Yilmaz, 2013).
Another study conducted on 199 European adults diagnosed with Functional Gastrointestinal
Disorders found the average body mass index to be 39.2, which is considered class II obesity
(Lahner et al., 2013). The findings in this study may differ from other studies due to the fact that
the participants were recruited from a fee-for-service Integrative Medicine office in Atlanta
where the majority of the patients are financially invested in their health and wellbeing.
Although it is no surprise, this study found a significant association between weight and
waist circumference. There was a positive correlation between weight and waist circumference;
as participants’ weight increased, their waist circumference increased as well. Also, as suspected,
the men in this study weighed more and had a larger waist circumference than females. These
two statistically significant findings were anticipated.
The researcher was specifically exploring the association between weight and waist
circumference on gastrointestinal quality of life and perceived stress. The results of this study
found no statistically significant correlation between waist circumference and gastrointestinal
quality of life or perceived stress. However, over the 8-week course of probiotics, digestive
enzymes, and glutamine there was a significant amount of weight loss. Surprisingly, based on
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this study’s research findings, waist circumference was not a good indicator for the impact of
Functional Gastrointestinal Disorders.
Perceived Stress
The results of this study validate the association between perceived stress and
gastrointestinal quality of life. This study reported a negative correlation between perceived
stress and gastrointestinal quality of life; as perceived stress increased, participants reported a
lower level of gastrointestinal quality of life. These findings are similar to other research studies.
Markert et al. (2014) conducted a study on 1857 participants, of that 62.78% met the criteria for
at least one Functional Gastrointestinal Disorder. The results of this study found that those with
higher levels of self-reported stress had worse gastrointestinal symptoms (Markert et al., 2014).
Another study was conducted on participants with irritable bowel syndrome (n = 105) to
examine the association between social support and the severity of irritable bowel syndrome
(Lackner et al., 2010). The Perceived Stress Scale was used to measure how the participants
appraised their stress. The study found that perceived stress was a statistically significant
predictor of pain severity (p < 0.05) (Lackner et al., 2010). Overall, this study validates that there
is a brain-gut connection. However, further research is needed to explore whether stress or
gastrointestinal symptoms is the initiating factor. In other words, is the association more braingut or gut-brain?

Gastrointestinal Quality of Life
Although this study did not have a control (healthy) group, the total gastrointestinal
quality of life scores were significantly lower than the normative results found in other studies;
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confirming individuals suffering from Functional Gastrointestinal Disorders have lower
gastrointestinal quality of life. Several other studies have confirmed the results found in this
study, that Functional Gastrointestinal Disorders are associated with lower gastrointestinal
quality of life (Sagawa et al., 2013; Miwa, 2012, Aro et al., 2011; Singh et al., 2012; Vu et al.,
2014).
However after the 8-week intervention of probiotics, digestive enzymes, and glutamine
there was a significant improvement in the participants’ self-reported gastrointestinal quality of
life. In the post-intervention survey, the participants’ gastrointestinal quality of life scores were
closer to the normative values seen in a healthy population, indicating significant improvements
in their symptoms with the intervention (Eypasch, 1995). Therefore, this gastrointestinal protocol
has the ability to improve individuals suffering from Functional Gastrointestinal Disorders
overall gastrointestinal quality of life.
Strengths of the Study
The researcher of this study has experience working with patients suffering from
Functional Gastrointestinal Disorders. In practice, this protocol has been shown to improve
patients’ gastrointestinal symptoms. However, this is the first research study to examine and
validate the combined benefits of probiotics, digestive enzymes, and glutamine on Functional
Gastrointestinal Disorders. The procedures involved in this study were safe to take with
additional medications or supplements. The primary purpose was to examine how the protocol
would work in the average patient as they conducted their normal life. One of the strengths of
this study was the large sample size (n = 98). The attrition rate was low (12.2%) with 86
completing the entire 8-week intervention. Another strength of the study was that all of the
instruments had strong internal consistency based on Cronbach’s alpha of greater than 0.7.
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Limitations of the Study
There were several limitations in this study. One of the largest limitations was that there
was not a control group to compare findings. Also, participants self-reported their own weight
and waist circumference increasing risk of human error. Since participants used their own scales
at home, there was no standardized calibration of the scales to ensure accuracy. All results were
self-reported and not validated through medical examination. However, the way a participant
perceives their gastrointestinal symptoms is essential to how they perceive their overall health.
The fewer symptoms patients experience the fewer medical office visits they will require; which
will ultimately decrease the costs associated with Functional gastrointestinal Disorders.
The participants did not complete the full Rome III Criteria survey to diagnosis
participants with specific Functional Gastrointestinal Disorders, such as irritable bowel
syndrome, functional constipation, functional dyspepsia, etc. Further research would be needed
to examine whether specific Functional Gastrointestinal Disorders respond better to the
intervention of probiotics, digestive enzymes, and glutamine.
Another limitation to the study was that the population examined was not diverse with the
majority of the participants being Caucasian and female; this is partly due to the fact that
participants were recruited from Atlanta Center for Holistic and Integrative Medicine where the
primary demographic is Caucasian and female. This study did not control for a number of
variables including dietary changes, alcohol intake, or prescribed medications that may alter the
findings. A prospective cohort study is a good way to measure outcomes over time, however
with this study design causality cannot be inferred.
Implications for Practice
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Several implications for healthcare practice can be derived from the findings of this
study. One of the significant findings, that is relevant to practice, is the higher level of perceived
stress participants report the lower their gastrointestinal quality of life. It is essential to
implement measures that encourage healthcare providers to address the whole patient including
their perceived level of stress.
Secondly, this intervention of probiotics, digestive enzymes, and glutamine resulted in
improvements in participants’ quality of life. Being that this protocol has been shown to be safe
and effective, implementing this protocol into practice has the ability to improve Functional
Gastrointestinal Disorder patients’ quality of life and decrease the costs associated with frequent
medical office visits related to gastrointestinal symptoms.
If feasible, healthcare providers should explore potential food allergies and sensitivities
that may be playing a key role in individuals’ abdominal pain related to food. As evident in this
research study, the gastrointestinal protocol significantly improved the participants’ abdominal
pain related to food. However, it would be beneficial to have an understanding of which foods
may be aggravating their symptoms.
Being that these three supplements are naturally derived from food and do not go through
the CYP450 system, there are less adverse effects and drug-drug interactions. Conventionally,
proton pump inhibitors are one of the most widely used drugs for reflux. These medications can
have detrimental effects on individuals overall health including malabsorption of B12, iron,
magnesium and decreased bone density (Ito & Jensen, 2010). Implementing the more natural
alternative of probiotics, digestive enzymes, and glutamine has been shown to be a safe and
effective treatment for managing Functional Gastrointestinal Disorder symptoms.
Implications for Theory Building
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Betty Neuman’s Healthcare System model was the foundation for this research study.
This model stresses the fact that each client’s system is unique with no two patients identical. On
a daily basis, the human body is exposed to known and unknown stressors that can disrupt the
body’s stability (Neuman, 1989). Based on the findings in this study, Betty Neuman’s Healthcare
System model could be expanded to specifically relate to individuals suffering from Functional
Gastrointestinal Disorders. It is clear that the gastrointestinal tract could be affected by a number
of stressors including food sensitivities, food allergies, emotional stress, or bacteria. The
digestive tract would remain the core with three surrounding lines of defense. Each line of
defense would represent a component of the gastrointestinal protocol including probiotics,
digestive enzymes, and glutamine. The primary purpose of the lines of defense is to strengthen
the digestive tract to prevent dysfunction from both internal and external stressors.
Future Research
Based on the results of this study, there are several areas that need additional research.
The participants in this study were not diverse. Further research is needed to evaluate the role
gender and ethnicity play on Functional Gastrointestinal Disorders. Possible theories for the
female predominance include hormonal variations and perceived stress; however, the exact
etiology behind the increased female prevalence remains vague and inconclusive.
Although minorities were shown to have lower gastrointestinal quality of life, the cause
for this correlation remains unknown. Initially, it was thought that perceived stress might be
contributing to lower gastrointestinal quality of life in minorities. However, the statistical
analysis did not support this hypothesis. Therefore, future research is needed to explain the
correlation between minorities and lower gastrointestinal quality of life.

RESTORING DIGESTIVE HEALTH

106

Also, this study examined the combined benefit of probiotics, digestive enzymes, and
glutamine; further research would be needed to determine which of the three of these
supplements makes the largest impact on gastrointestinal symptoms. Lastly, further research is
needed to determine whether these supplements actually restore digestive health or whether they
just temporarily improve the symptoms. Therefore, future follow up with the participants is
necessary to determine whether the symptoms returned after completing the 8-week intervention.
Dissemination
The research findings were disseminated through a podium presentation at Georgia
Nursing Leadership Coalition’s Doctoral Symposium in November 2015. The findings of this
study will be shared with each of the three supplement companies including Metagenics,
Orthomolecular, and Integrative Therapeutics. The author plans to apply for publication with the
Functional Medicine Journal, the American Journal of Gastroenterology, the Journal for Nurse
Practitioners, or Journal of Family Medicine and Primary Care.
Conclusion
This study adds to the body of literature that explores effective therapies for addressing
Functional Gastrointestinal Disorders. This population often has little to no improvement in their
symptoms with conventional therapies focusing on symptom management. Functional
Gastrointestinal Disorders have a negative effect on patients overall health. The intervention of
probiotics, digestive enzymes, and glutamine has been shown to be safe, natural, and effective
for reducing gastrointestinal symptoms. While this study is the first to collectively examine the
benefits of probiotics, digestive enzymes, and glutamine, the science behind each component is
evident. After the 8-week intervention, there were significant improvements in weight loss and
gastrointestinal quality of life. Therefore, this protocol has the power to transform patient’s
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quality of life and reduce the overall healthcare cost associated with Functional Gastrointestinal
Disorders.
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Appendix B
Recruiting Flyer
Suffering with Digestive Issues?
Do you have bloating, constipation, diarrhea, flatulence, reflux, or abdominal pain?
We may have the solution for you!
Atlanta Center for Holistic and Integrative Medicine is starting a research study to help restore
your digestive health THIS summer and we NEED you!
This research study will be conducted over 8 weeks. As a participant of the study, you will
receive all supplements FREE OF CHARGE. Over the 8 weeks, you will be responsible for
taking a pre and post survey, responding to a brief weekly email, and taking the daily
supplements as recommended.
Please see the inclusion and exclusion criteria below to see if you may qualify. If you are
interested please email kristin.corbin@bobcats.gcsu.edu for more information.
Inclusion Criteria:
 Male or female aged 18-65 years old
 Current digestive symptoms
 Physical exam within the past 12 months
 Proficient in English
 Have internet access for weekly emails
 Own a scale and measuring tape in centimeter
 Be willing to sign an informed consent
Exclusion Criteria:
 Younger than 18 years old or older than 65 years old
 Pregnant or nursing
 Diagnosed with an organic disease, such as Crohn’s disease, ulcerative colitis, or
gastrointestinal tumors
 You will be excluded from this study if you respond “yes” to any of the following
questions:
o In the past 3 months, have you noticed blood in your stools?
o In the past 3 months, have you noticed black stools, unrelated to iron
supplements?
o In the past 3 months, how often have you vomited blood?
o Have you been told by your doctor that you are anemic (if female, not due to your
menstrual cycle)?
o In the past 3 months, have you lost 10 lbs of weight unintentionally?
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o If over the age of 50, have you had a recent major change in bowel movements?
o In the past 3 months, have you had persistent or worsening hoarseness of the
voice?
o In the past 3 months, have you had persistent or worsening neck or throat pain?
o In the past 3 months, have you had chest pain on exertion, or chest pain related to
heart problems?
o In the past 3 months, have you had difficulty swallowing?
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Appendix C
Informed Consent
Informed Consent Form
Restoring Digestive Health
With Probiotics, Digestive Enzymes, and Glutamine
PURPOSE OF RESEARCH
You are invited to participate in a research study on restoring digestive health. The primary goal
of this research study is to determine whether a well-established protocol used at Atlanta Center
for Holistic and Integrative Medicine is effective at restoring digestive health. This protocol
utilizes probiotics, digestive enzymes, and glutamine.
You were selected as a possible participant in this study because you are currently suffering from
gastrointestinal symptoms. This research study is looking for 100 participants with functional
gastrointestinal disorders including reflux, constipation, diarrhea, nausea, abdominal pain,
bloating, and irritable bowel syndrome.
VOLUNTARY PARTICIPATION
Your participation in this study is entirely voluntary. You are free to terminate your participation
in this study at any point without reason. If you decide to terminate your participation, please
notify Kristin Corbin at kristin.corbin@bobcats.gcsu.edu.
INCLUSION AND EXCLUSION CRITERIA
By signing this informed consent you are agreeing to the sample criteria. Please read through the
inclusion and exclusion criteria entirely.
Inclusion Criteria:
 Male or female aged 18-65 years old
 Current digestive symptoms
 Physical exam within the past 12 months
 Proficient in English
 Have internet access for weekly emails
 Own a scale and measuring tape in centimeter
 Be willing to sign an informed consent
Exclusion Criteria:
 Younger than 18 years old or older than 65 years old
 Pregnant or nursing
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Diagnosed with an organic disease, such as Crohn’s disease, ulcerative colitis, or
gastrointestinal tumors
Please read and answer the questions below thoroughly:
o In the past 3 months, have you noticed blood in your stools?
_____ Yes
_____ No
o In the past 3 months, have you noticed black stools, unrelated to iron
supplements?
_____ Yes
_____ No
o In the past 3 months, how often have you vomited blood?
_____ Yes
_____ No
o Have you been told by your doctor that you are anemic (if female, not due to your
menstrual cycle)?
_____ Yes
_____ No
o In the past 3 months, have you lost 10 lbs of weight unintentionally?
_____ Yes
_____ No
o If over the age of 50, have you had a recent major change in bowel movements?
_____ Yes
_____ No
o In the past 3 months, have you had persistent or worsening hoarseness of the
voice?
_____ Yes
_____ No
o In the past 3 months, have you had persistent or worsening neck or throat pain?
_____ Yes
_____ No
o In the past 3 months, have you had chest pain on exertion, or chest pain related to
heart problems?
_____ Yes
_____ No
o In the past 3 months, have you had difficulty swallowing?
_____ Yes
_____ No

DURATION OF STUDY INVOLVEMENT
This research study is expected to take 8 weeks. The study is estimated to start June 29, 2015.
PROCEDURES
If you choose to participate, you will be asked to complete a pre and post intervention
questionnaire and measurements including weight and waist circumference. The initial and post
questionnaire is estimated to take 20-30 minutes to complete. Over the course of the 8 weeks,
you will receive a brief weekly email with four questions to answer including (1) how many
supplements were missed in the previous week, (2) what is your current weight, (3) what is your
current waist circumference, and (4) any additional comments you would like to share. The
weekly email is estimated to take 5-10 minutes to complete.
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The intervention for this study consists of probiotics, digestive enzymes, and glutamine. It is
important that these supplements are taken daily. The probiotics and glutamine are taken by
mouth in the morning and the digestive enzymes can be taken with your largest meal of the day.
The brands most commonly used at Atlanta Center for Holistic and Integrative Medicine will be
used for the study. You will receive the probiotics, digestive enzymes, and glutamine for free.
Orthomolecular, Integrative Therapeutics, and Metagenics donated the supplements for the
purpose of this study. Kristin Corbin does not have any financial benefits from using these
products, nor is she invested in the companies in anyway.
Risks:
The risks associated with each of these supplements are minimal. The only associated side effects
found is mild cramping, abdominal pain, or bloating.
IF YOU FEEL DISCOMFORT AT ANY TIME, NOTIFY KRISTIN CORBIN AT
KRISTIN.CORBIN@BOBCATS .GCSU.EDU AND DISCONTINUE THE
SUPPLEMENTS.
The results of the study will remain anonymous and will not be linked with your name. The
results are to be used for research purposes only.

PARTICIPANT RESPONSIBILITIES
As a participant, your responsibilities include:
 Follow the instructions outlined in the introduction video
 Complete the pre and post questionnaire
 Complete the weekly email questionnaire
 Take the study supplements as instructed
 Tell the researcher about any side effects you may experience
 Tell the researcher if you believe you might be pregnant
 Keep the study supplement in a safe and cool place- out of the direct sun
 Ask questions as needed
 Tell the researcher if you would like to terminate your participation

WITHDRAWAL FROM STUDY
If you first agree to participate and then change your mind, you are free to withdraw your
consent and discontinue your participation at any time. If you decide to withdraw your consent to
participate in this study, you should notify Kristin Corbin at Kristin.corbin@bobcats.gcsu.edu
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POTENTIAL BENEFITS
The researcher cannot guarantee or promise that you will receive any benefits from this study.
However, this well-established protocol has been found beneficial at Atlanta Center for Holistic
and Integrative Medicine.
PARTICIPANT’S RIGHTS
You should not feel obligated to agree to participate. Your questions should be answered clearly
and to your satisfaction. If you decide not to participate, tell the researcher, Kristin Corbin.
FINANCIAL CONSIDERATIONS
There are no costs associated with this research study. All necessary supplements will be given
to you at no cost.
CONFIDENTIALITY
The purpose of this research study is to obtain data or information on the safety and effectiveness
of probiotics, digestive enzymes, and glutamine; the results may be disseminated in medical
journals, healthcare conferences, and poster presentations. Your identity and/or your personal
health information will not be disclosed. Prior to beginning the study you will receive a unique
identification number that you will be prompted to input on each questionnaire rather than your
name.

________________________________
Signature of Adult Participant

______________
Date
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Appendix D
Participants Study Checklist
Items to Complete

Estimated Date

Sign Informed Consent

June 15, 2015

Pick Up Supplements

By June 20, 2015

Watch the Introduction Video

By June 25, 2015

Watch the “How to Measure
Weight and Waist
Circumference” Video

By June 25, 2015

Complete the pre-intervention
questionnaires

By June 28, 2015

Start the supplements

July 1, 2015

Week 1 Email

July 8, 2015

Week 2 Email

July 15, 2015

Week 3 Email

July 22, 2015

Week 4 Email

July 29, 2015

Week 5 Email

August 5, 2015

Week 6 Email

August 12, 2015

Week 7 Email

August 19, 2015

Week 8: Post-intervention
questionnaire

August 26, 2015

Completed Date

